00000000|MMI|24.11|Stable angina|C0340288|[dsyn]|["Angina, Stable"-tx-1-"stable angina"-noun-0]|TX|65/13|C10.597.617.192.500.575;C14.280.647.187.362;C14.907.585.187.362;C23.888.592.612.233.500.575
00000000|MMI|3.68|Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2598112|[clna]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|95/14|
00000000|MMI|3.68|Date of admission|C1302393|[tmco]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|95/14|
00000000|MMI|3.65|Report status|C0586177|[fndg]|["Report status"-tx-1-"Report Status"-noun-0]|TX|121/13|
00000000|MMI|3.64|10 - 12|C3843787|[fndg]|["10 - 12"-tx-1-"10 12"-fraction-0]|TX|41/2,51/2|
00000000|MMI|3.59|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-1-"PUO"-noun-0]|TX|12/3|
00000000|MMI|3.47|CALD1 wt Allele|C3813548|[gngm]|["CAD"-tx-1-"CAD"-adj-0]|TX|81/3|
00000000|MMI|3.47|Diagnostic interview schedule|C0451119|[inpr]|["DIS"-tx-1-"DIS"-noun-0]|TX|89/3|
00000000|MMI|3.47|Discontinued|C1444662|[fndg]|["DIS"-tx-1-"DIS"-noun-0]|TX|89/3|
00000000|MMI|119.05|Aspirin|C0004057|[orch,phsu]|["ASA"-tx-9-"asa"-noun-0,"ASA"-tx-8-"asa"-noun-0,"ASA"-tx-3-"ASA"-noun-0]|TX|[2075/3],[2945/3];1885/3;342/3|D02.455.426.559.389.657.410.595.176
00000000|MMI|105.34|Barbados|C0004739|[geoa]|["BB"-tx-15-"BB"-noun-0,"BB"-tx-12-"bb"-noun-0,"BB"-tx-11-"BB"-noun-0,"BB"-tx-10-"bb"-noun-0,"BB"-tx-9-"bb"-noun-0,"BB"-tx-8-"bb"-noun-0]|TX|4297/2;3283/2;3222/2;3116/2;2951/2;1891/2|Z01.107.084.900.140;Z01.639.880.140
00000000|MMI|101.53|Patient Discharge|C0030685|[hlca]|["Discharge"-tx-16-"DISCHARGE"-noun-0,"Discharge"-tx-15-"DISCHARGE"-noun-0,"Discharge"-tx-3-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0,"Patient Discharge"-tx-1-"DISCHARGE PATIENT"-noun-0]|TX|4455/9;4199/9;1002/9;39/9;107/17|E02.204.125;E02.760.400.610;N02.421.192.125;N02.421.585.400.610;N04.590.233.727.210.125
00000000|MMI|93.04|Cerebroside-Sulfatase|C0007804|[aapp,enzy]|["ASA"-tx-9-"asa"-noun-0,"ASA"-tx-8-"asa"-noun-0,"ASA"-tx-3-"ASA"-noun-0]|TX|[2075/3],[2945/3];1885/3;342/3|D08.811.277.352.827.070.250
00000000|MMI|88.14|Obesity|C0028754|[dsyn]|["OBESE"-tx-9-"obese"-adj-1,"OBESITY"-tx-9-"obesity"-noun-0,"OBESITY"-tx-3-"obesity"-noun-0]|TX|2444/5;1976/7;1228/7|C18.654.726.500;C23.888.144.699.500;E01.370.600.115.100.160.120.699.500;G07.100.100.160.120.699.500
00000000|MMI|76.00|Portugal|C0032729|[geoa]|["PO"-tx-3-"PO"-noun-0,"PO"-tx-1-"Po"-noun-0]|TX|[353/2],[393/2],[431/2],[470/2],[575/2],[666/2];91/2|Z01.542.727
00000000|MMI|68.28|Coding|C0009219|[ocac]|["code"-tx-13-"CODE"-noun-0,"code"-tx-3-"CODE"-noun-0,"code"-tx-3-"code"-noun-0]|TX|3682/4;263/4;281/4|N04.452.758.708.200.400.500;N04.452.859.564.274;N05.715.360.300.715.500.249;N06.850.520.308.940.968.249
00000000|MMI|67.88|Mongolia|C0026410|[geoa]|["MG"-tx-8-"mg"-noun-0,"MG"-tx-3-"MG"-noun-0]|TX|1906/2;[350/2],[390/2],[428/2],[467/2]|Z01.252.474.651
00000000|MMI|58.91|Atenolol|C0004147|[orch,phsu]|["ATENOLOL"-tx-13-"atenolol"-noun-0,"ATENOLOL"-tx-9-"atenolol"-noun-0,"ATENOLOL"-tx-3-"ATENOLOL"-noun-0]|TX|3841/8;2044/8;584/8|D02.033.100.624.698.070;D02.033.755.624.698.070;D02.092.063.624.698.070
00000000|MMI|49.79|Lipitor|C0593906|[orch,phsu]|["Lipitor"-tx-9-"lipitor"-noun-0,"Lipitor"-tx-3-"LIPITOR"-noun-0]|TX|[2062/7],[2956/7];362/7|D03.383.129.578.075;D10.251.450.200
00000000|MMI|48.50|Walking (activity)|C0080331|[dora]|["Walk"-tx-6-"walks"-verb-0,"Walking"-tx-3-"Walking"-verb-0]|TX|1699/5;810/7|G11.427.590.530.568.900;G11.427.590.530.698.277.937;I03.350.937;I03.450.642.845.940
00000000|MMI|48.50|diagnosis aspect|C1704338|[qlco]|["diagnosis"-tx-3-"DIAGNOSIS"-noun-0]|TX|[957/9],[1097/9]|x.x.x.x.x.x.x
00000000|MMI|45.23|Adenine Nucleotide Translocase|C1141015|[aapp,bacs]|["ANT"-tx-9-"ant"-adj-0,"ANT"-tx-3-"ant"-adj-0]|TX|1956/3;1473/3|D12.776.157.530.625.875.500;D12.776.543.585.450.162.225;D12.776.543.585.475.500;D12.776.543.585.625.875.500;D12.776.575.750.500
00000000|MMI|45.23|Ants|C0003455|[euka]|["Ant"-tx-9-"ant"-adj-0,"Ant"-tx-3-"ant"-adj-0]|TX|1956/3;1473/3|B01.050.500.131.617.479.205
00000000|MMI|42.15|Migraine Disorders|C0149931|[dsyn]|["MIGRAINE"-tx-9-"migraine"-noun-0,"MIGRAINES"-tx-3-"migraines"-noun-0]|TX|1965/8;1238/9|C10.228.140.546.399.750
00000000|MMI|40.50|Netherlands|C0027778|[geoa]|["NL"-tx-9-"nl"-noun-0,"NL"-tx-7-"nL"-noun-0]|TX|[2717/2],[2725/2],[2736/2];1837/2|Z01.542.651
00000000|MMI|40.26|Dyslipidemias|C0242339|[dsyn]|["Dyslipidemia"-tx-9-"dyslipidemia"-noun-0,"Dyslipidemia"-tx-3-"dyslipidemia"-noun-0]|TX|2025/12;[1213/12],[1527/12]|C18.452.584.500
00000000|MMI|40.14|Rabbi|C0684010|[prog]|["R."-tx-12-"R"-noun-0,"R."-tx-9-"r"-adj-0,"R."-tx-3-"R"-noun-0]|TX|3246/1;2342/1;1363/1|M01.526.799.500
00000000|MMI|40.05|Leukocytes|C0023516|[cell]|["WBC"-tx-13-"WBC"-noun-0,"WBC"-tx-9-"WBC"-noun-0,"WBC"-tx-9-"wbc"-noun-0]|TX|3396/3;2538/3;2477/3|A11.118.637;A15.145.229.637;A15.382.490
00000000|MMI|39.05|Nexium|C0939400|[orch,phsu]|["Nexium"-tx-13-"nexium"-noun-0,"Nexium"-tx-3-"NEXIUM"-noun-0]|TX|3528/6;440/6|D02.886.640.074.500.500;D03.383.725.024.500.500;D03.438.103.034.500.500
00000000|MMI|35.02|Hypertensive disease|C0020538|[dsyn]|["HTN"-tx-9-"htn"-noun-0,"HTN"-tx-3-"HTN"-noun-0,"HTN"-tx-3-"htn"-noun-0]|TX|2019/3;1207/3;1521/3|C14.907.489
00000000|MMI|33.08|Nitrates|C0028125|[chvs]|["Nitrate"-tx-10-"nitrate"-noun-0,"Nitrate"-tx-9-"nitrate"-noun-0]|TX|3106/7;2966/7|D01.248.497.158.606;D01.625.525.550;D02.583
00000000|MMI|32.74|Erythromycin|C0014806|[antb,orch]|["ERYTHROMYCIN"-tx-9-"erythromycin"-noun-0,"ERYTHROMYCINS"-tx-3-"Erythromycins"-noun-0]|TX|2118/12;937/13|D02.540.576.500.992
00000000|MMI|32.70|Iodides|C0021966|[inch]|["I-"-tx-10-"i"-noun-0,"I-"-tx-9-"I"-noun-0]|TX|3121/1;2935/1|D01.248.497.158.490;D01.475.410
00000000|MMI|32.68|Electrocardiogram|C0013798|[fndg]|["EKG"-tx-9-"EKG"-noun-0,"EKG"-tx-3-"ekg"-noun-0]|TX|2608/3;1553/3|E01.370.370.380.240;E01.370.405.240
00000000|MMI|32.68|Electrocardiography|C1623258|[diap]|["EKG"-tx-9-"EKG"-noun-0,"EKG"-tx-3-"ekg"-noun-0]|TX|2608/3;1553/3|E01.370.370.380.240;E01.370.405.240
00000000|MMI|32.65|Dizziness|C0012833|[sosy]|["Dizzyness"-tx-6-"dizziness"-noun-1,"DIZZY"-tx-5-"dizzy"-adj-0]|TX|1785/9;1650/5|C10.597.751.237;C23.888.592.763.237
00000000|MMI|32.46|Dominican Republic|C0013014|[geoa]|["DR"-tx-13-"dr"-noun-0,"DR"-tx-3-"DR"-noun-0]|TX|3724/2;863/2|Z01.107.084.900.300;Z01.639.880.300
00000000|MMI|32.36|Latvia|C0023128|[geoa]|["LV"-tx-9-"LV"-noun-0]|TX|[2739/2],[2770/2]|Z01.542.248.136.560;Z01.586.950.140.560
00000000|MMI|29.82|Nasal sinus|C0030471|[bsoj]|["Sinus"-tx-12-"sinus"-noun-0,"Sinus"-tx-9-"sinus"-noun-0]|TX|3258/5;[1936/5],[2613/5]|A04.531.621
00000000|MMI|29.82|pathologic fistula|C0016169|[anab]|["Sinus"-tx-12-"sinus"-noun-0,"Sinus"-tx-9-"sinus"-noun-0]|TX|3258/5;[1936/5],[2613/5]|C23.300.575
00000000|MMI|28.70|aminosalicylic acid|C0030125|[orch,phsu]|["PAS"-tx-9-"PAS"-noun-0]|TX|2798/3|D02.241.223.100.050.500.642;D02.241.223.100.300.595.100.060;D02.241.511.390.595.100.060;D02.455.426.559.389.127.020.937.642;D02.455.426.559.389.127.281.595.100.060;D02.455.426.559.389.657.410.595.100.060
00000000|MMI|27.36|Daily|C0332173|[tmco]|["everyday"-tx-13-"everyday"-adj-0,"QD"-tx-9-"qd"-noun-0,"Daily"-tx-3-"DAILY"-adj-0,"Daily"-tx-3-"DAILY"-adv-0]|TX|3801/8;2057/2;[356/5],[396/5],[434/5],[473/5],[578/5];[356/5],[396/5],[434/5],[473/5],[578/5]|
00000000|MMI|26.89|Oral|C0442027|[spco]|["PO"-tx-3-"PO"-noun-0,"PO"-tx-1-"Po"-noun-0]|TX|[353/2],[393/2],[431/2],[470/2],[575/2],[666/2];91/2|
00000000|MMI|26.74|Christmas Island|C0006888|[geoa]|["CXR"-tx-13-"cxr"-noun-0,"CXR"-tx-9-"CXR"-noun-0]|TX|3335/3;2597/3|Z01.639.100;Z01.678.100.373
00000000|MMI|26.56|ECHO protocol|C0058928|[topp]|["ECHO"-tx-10-"echo"-noun-0,"ECHO"-tx-9-"ECHO"-noun-0]|TX|3132/4;2687/4|x.x.x.x
00000000|MMI|26.34|Diet|C0012155|[food]|["Diet"-tx-13-"diet"-noun-0,"Diet"-tx-3-"DIET"-noun-0]|TX|3512/4;684/4|G07.203.650.240
00000000|MMI|26.30|Solomon Islands|C0037623|[geoa]|["BP"-tx-11-"BP"-noun-0,"BP"-tx-9-"bp"-noun-0]|TX|3201/2;2330/2|Z01.639.760.590
00000000|MMI|26.22|Infantile Neuroaxonal Dystrophy|C0270724|[dsyn]|["PLAN"-tx-15-"PLAN"-noun-0,"PLAN"-tx-10-"plans"-noun-1]|TX|4239/4;3068/5|C10.228.140.744
00000000|MMI|26.14|Panama|C0030266|[geoa]|["PM"-tx-16-"PM"-noun-0,"PM"-tx-1-"PM"-adj-0]|TX|4438/2;146/2|Z01.107.169.772
00000000|MMI|26.11|Physicians|C0031831|[prog]|["DR"-tx-13-"dr"-noun-0,"DR"-tx-3-"DR"-noun-0]|TX|3724/2;863/2|M01.526.485.810;N02.360.810
00000000|MMI|26.00|Pneumocystis jiroveci pneumonia|C1535939|[dsyn]|["PCP"-tx-13-"PCP"-noun-0,"PCP"-tx-3-"PCP"-noun-0]|TX|3651/3;859/3|C01.703.534.700;C01.703.770.700;C08.381.472.700;C08.381.677.675;C08.730.435.700;C08.730.610.675
00000000|MMI|25.76|Residual volume|C0035190|[clna]|["RV"-tx-9-"RV"-noun-0]|TX|2720/2|E01.370.386.700.485.750.275.650;G09.772.850.390.820
00000000|MMI|25.68|Nicotiana|C0086707|[plnt]|["Tobacco"-tx-9-"tobacco"-noun-0]|TX|2168/7|B01.650.940.800.575.100.905.900
00000000|MMI|25.68|Nicotiana tabacum|C0740009|[plnt]|["Tobacco"-tx-9-"tobacco"-noun-0]|TX|2168/7|B01.650.940.800.575.100.905.900
00000000|MMI|24.11|Creatine Kinase MB Isoenzyme|C0010290|[aapp,enzy]|["CK-MB"-tx-9-"ck/mb"-noun-0]|TX|2519/5|D08.811.913.696.640.150.625
00000000|MMI|24.11|Stable angina|C0340288|[dsyn]|["Angina, Stable"-tx-3-"stable angina"-noun-0]|TX|1071/13|C10.597.617.192.500.575;C14.280.647.187.362;C14.907.585.187.362;C23.888.592.612.233.500.575
00000000|MMI|24.11|Syncope|C0039070|[sosy]|["SYNCOPE"-tx-6-"syncope"-noun-1]|TX|1775/7|C10.597.606.358.800.600;C23.888.592.604.359.800.600
00000000|MMI|23.80|Bounded by|C0332297|[spco]|["BB"-tx-15-"BB"-noun-0,"BB"-tx-12-"bb"-noun-0,"BB"-tx-11-"BB"-noun-0,"BB"-tx-10-"bb"-noun-0,"BB"-tx-9-"bb"-noun-0,"BB"-tx-8-"bb"-noun-0]|TX|4297/2;3283/2;3222/2;3116/2;2951/2;1891/2|
00000000|MMI|22.56|Surgical aspects|C0038895|[ftcn]|["operations"-tx-3-"OPERATIONS"-noun-0]|TX|1280/10|x.x.x.x.x.x.x
00000000|MMI|22.46|Trimethoprim-Sulfamethoxazole Combination|C0041044|[phsu]|["Trimethoprim-sulphamethoxazole"-tx-3-"TRIMETHOPRIM/SULFAMETHOXAZOLE"-noun-0]|TX|621/29|D02.065.884.725.867.500;D02.092.146.807.867.500;D02.886.590.700.725.867.500;D03.383.742.906.500;D26.310.875
00000000|MMI|22.38|therapeutic aspects|C0039798|[ftcn]|["treatment"-tx-3-"Treatment"-noun-0]|TX|1159/9|x.x.x.x.x.x.x
00000000|MMI|20.95|Angiotensin-Converting Enzyme Inhibitors|C0003015|[phsu]|["ACE Inhibitor"-tx-3-"ACE Inhibitor"-noun-0]|TX|921/13|D27.505.519.389.745.085
00000000|MMI|20.95|Colace|C0282139|[orch,phsu]|["Colace"-tx-13-"colace"-noun-0]|TX|3519/6|D02.241.081.337.759.249
00000000|MMI|20.95|Esomeprazole|C0937846|[orch,phsu]|["ESOMEPRAZOLE"-tx-3-"ESOMEPRAZOLE"-noun-0]|TX|449/12|D02.886.640.074.500.500;D03.383.725.024.500.500;D03.438.103.034.500.500
00000000|MMI|20.95|Urethral Stricture|C0041974|[patf]|["URETHRAL STRICTURE"-tx-9-"urethral stricture"-noun-0]|TX|1998/18|C12.777.767.700.700;C13.351.968.767.700.700
00000000|MMI|20.95|Vision|C0042789|[orgf]|["see"-tx-9-"see"-verb-0]|TX|3052/3|F02.830.816.964;G02.111.087.800.480.900;G02.149.115.800.480.900;G04.299.880.480.900;G11.561.600.810.964;G14.640.816
00000000|MMI|20.39|Edema|C0013604|[fndg]|["OEDEMA"-tx-9-"edema"-noun-1,"OEDEMA"-tx-6-"edema"-noun-1]|TX|2425/5;1752/5|C23.888.277
00000000|MMI|20.30|Disease|C0012634|[dsyn]|["condition"-tx-15-"CONDITION"-noun-0,"condition"-tx-3-"Conditions"-noun-0]|TX|4209/9;1107/10|C23.550.288
00000000|MMI|20.10|Hospital admission|C0184666|[hlca]|["Admit"-tx-9-"admit"-verb-0,"Admission"-tx-3-"Admission"-noun-0,"Admit"-tx-3-"ADMIT"-verb-0,"admitted"-tx-3-"admitted"-verb-0]|TX|[2360/5],[2458/5];1059/9;951/5;1540/8|
00000000|MMI|20.00|Diet therapy|C0012159|[hlca]|["Diet"-tx-13-"diet"-noun-0,"Diet"-tx-3-"DIET"-noun-0]|TX|3512/4;684/4|E02.642.249
00000000|MMI|19.95|CALD1 wt Allele|C3813548|[gngm]|["CAD"-tx-9-"cad"-noun-0,"CAD"-tx-3-"CAD"-noun-0,"H-CAD"-tx-3-"h cad"-noun-0]|TX|[1950/3],[2264/3];[1087/3],[1201/3];1463/1,1467/3|
00000000|MMI|19.85|Exanthema|C0015230|[sosy]|["RASH"-tx-9-"rash"-noun-0]|TX|[2133/4],[2146/4]|C17.800.257
00000000|MMI|19.48|+2|C0740116|[qnco]|["+2"-tx-15-"2"-integer-0,"+2"-tx-13-"2"-integer-0,"+2"-tx-9-"2"-integer-0]|TX|4274/1;[3317/1],[3402/1],[3749/1];2544/1|
00000000|MMI|19.48|2+|C3833492|[fndg]|["2+"-tx-15-"2"-integer-0,"2+"-tx-13-"2"-integer-0,"2+"-tx-9-"2"-integer-0]|TX|4274/1;[3317/1],[3402/1],[3749/1];2544/1|
00000000|MMI|19.48|2+ Score|C2827735|[qnco]|["2+"-tx-15-"2"-integer-0,"2+"-tx-13-"2"-integer-0,"2+"-tx-9-"2"-integer-0]|TX|4274/1;[3317/1],[3402/1],[3749/1];2544/1|
00000000|MMI|19.48|2+ Score, WHO|C2981700|[clas]|["2+"-tx-15-"2"-integer-0,"2+"-tx-13-"2"-integer-0,"2+"-tx-9-"2"-integer-0]|TX|4274/1;[3317/1],[3402/1],[3749/1];2544/1|
00000000|MMI|19.45|International Normalized Ratio|C0525032|[lbpr]|["INR"-tx-9-"inr"-noun-0]|TX|2496/3|E01.370.225.625.115.320;E05.200.625.115.320
00000000|MMI|19.31|District of Columbia|C0012764|[geoa]|["D.C."-tx-1-"D/C"-noun-0]|TX|185/3|Z01.107.567.875.500.210;Z01.433.429
00000000|MMI|19.26|Isosorbide Dinitrate|C0022252|[orch,phsu]|["ISOSORBIDE DINITRATE"-tx-9-"isosorbide dinitrate"-noun-0]|TX|2085/20|D02.033.800.813.480.500;D09.853.813.480.500
00000000|MMI|19.02|4+ Answer to question|C3838679|[fndg]|["4+"-tx-10-"4"-fraction-0,"4+"-tx-9-"4"-fraction-0,"4+"-tx-3-"4"-fraction-0]|TX|3142/1;[2694/1],[2816/1],[3046/1];1307/1|
00000000|MMI|18.17|Magnesium Cation|C2346927|[elii,phsu]|["Mg++"-tx-8-"mg"-noun-0,"Mg++"-tx-3-"MG"-noun-0]|TX|1906/2;[350/2],[390/2],[428/2],[467/2]|
00000000|MMI|18.17|Milligram percent|C1960952|[qnco]|["mg %"-tx-8-"mg"-noun-0,"mg %"-tx-3-"MG"-noun-0]|TX|1906/2;[350/2],[390/2],[428/2],[467/2]|
00000000|MMI|18.17|mg/dL|C0439269|[qnco]|["mg%"-tx-8-"mg"-noun-0,"mg%"-tx-3-"MG"-noun-0]|TX|1906/2;[350/2],[390/2],[428/2],[467/2]|
00000000|MMI|17.80|Cerebrovascular accident|C0038454|[dsyn]|["STROKE"-tx-9-"stroke"-noun-1]|TX|2270/6|C10.228.140.300.775;C14.907.253.855
00000000|MMI|17.80|Chest Pain|C0008031|[sosy]|["CHEST PAIN"-tx-14-"chest pain"-noun-0]|TX|4109/10|C10.597.617.192;C23.888.592.612.233
00000000|MMI|17.80|Vertigo|C0042571|[sosy]|["dizziness"-tx-6-"dizziness"-noun-1]|TX|1785/9|C09.218.568.900.883;C10.597.951;C23.888.592.958
00000000|MMI|16.30|Creatinine|C0010294|[bacs,orch]|["CREATININE"-tx-13-"creatinine"-noun-0]|TX|3454/10|D03.383.129.308.207
00000000|MMI|16.30|Hematocrit procedure|C0018935|[lbpr]|["HCT"-tx-9-"hct"-noun-0]|TX|2487/3|E01.370.225.625.400;E05.200.625.400;G09.188.370.374
00000000|MMI|16.30|Hemopoietic stem cell transplant|C0472699|[topp]|["HCT"-tx-9-"hct"-noun-0]|TX|2487/3|E04.936.225.687.500
00000000|MMI|16.25|Saint Kitts and Nevis|C0282380|[geoa]|["SC"-tx-13-"sc"-noun-0]|TX|3583/2|Z01.107.084.900.787;Z01.639.880.787
00000000|MMI|16.23|Ivory Coast|C0022326|[geoa]|["IV"-tx-8-"iv"-noun-0]|TX|1909/2|Z01.058.290.190.272
00000000|MMI|16.23|Treatment Protocols|C0040808|[topp]|["Regimen"-tx-14-"regimen"-noun-0]|TX|4062/7|E02.183;N05.715.360.775.225
00000000|MMI|16.22|Mucomyst|C0699252|[aapp,phsu]|["Mucomyst"-tx-13-"mucomyst"-noun-0]|TX|3467/8|D02.886.030.230.259;D12.125.166.230.259
00000000|MMI|16.18|Isosorbide|C0022251|[orch,phsu]|["ISOSORBIDE"-tx-13-"isosorbide"-noun-0]|TX|3893/10|D02.033.800.813.480;D09.853.813.480
00000000|MMI|16.17|Antibiotics|C0003232|[antb]|["Antibiotic"-tx-13-"antibiotic"-adj-0]|TX|3937/10|D27.505.954.122.085
00000000|MMI|16.12|Coronary Arteriosclerosis|C0010054|[dsyn]|["coronary artery disease"-tx-3-"coronary artery disease"-noun-0]|TX|968/23|C14.280.647.250.260;C14.907.137.126.339;C14.907.585.250.260
00000000|MMI|16.12|Coronary Artery Disease|C1956346|[dsyn]|["CORONARY ARTERY DISEASE"-tx-3-"coronary artery disease"-noun-0]|TX|968/23|C14.280.647.250.260;C14.907.137.126.339;C14.907.585.250.260
00000000|MMI|16.12|Fluorides|C0016327|[inch,phsu]|["F-"-tx-13-"f"-noun-0]|TX|3659/1|D01.248.497.158.380;D01.303.350.300
00000000|MMI|16.12|Lebanon|C0023190|[geoa]|["LE"-tx-6-"le"-adj-0]|TX|1749/2|Z01.252.245.500.450
00000000|MMI|16.12|Records|C0034869|[inpr]|["Records"-tx-7-"records"-noun-0]|TX|1845/7|E05.318.308.940;L01.280.900;N04.452.859;N05.715.360.300.715;N06.850.520.308.940
00000000|MMI|16.09|Oman|C0028971|[geoa]|["OM"-tx-9-"OM"-noun-0]|TX|2851/2|Z01.252.245.500.600
00000000|MMI|16.09|Poverty|C0032854|[grpa]|["Poor"-tx-9-"poor"-adj-0]|TX|2627/4|I01.880.735.634;I01.880.853.996.535;N01.824.600
00000000|MMI|16.05|Proton Pump Inhibitors|C0358591|[phsu]|["PPI"-tx-3-"PPI"-noun-0]|TX|540/3|D27.505.519.389.848
00000000|MMI|16.05|prepulse inhibition activity|C0871125|[phsf]|["PPI"-tx-3-"PPI"-noun-0]|TX|540/3|G11.561.600.812.500
00000000|MMI|15.79|1+|C3816745|[fndg]|["1+"-tx-15-"1"-integer-0,"1+"-tx-13-"1"-integer-0,"1+"-tx-9-"1"-integer-0]|TX|4245/1;3708/1;2925/1|
00000000|MMI|15.79|1+ Score|C2827734|[qnco]|["1+"-tx-15-"1"-integer-0,"1+"-tx-13-"1"-integer-0,"1+"-tx-9-"1"-integer-0]|TX|4245/1;3708/1;2925/1|
00000000|MMI|15.79|1+ Score, WHO|C2981698|[clas]|["1+"-tx-15-"1"-integer-0,"1+"-tx-13-"1"-integer-0,"1+"-tx-9-"1"-integer-0]|TX|4245/1;3708/1;2925/1|
00000000|MMI|15.03|Arylsulfatase A, human|C3853627|[aapp,enzy]|["ASA"-tx-9-"asa"-noun-0,"ASA"-tx-8-"asa"-noun-0,"ASA"-tx-3-"ASA"-noun-0]|TX|[2075/3],[2945/3];1885/3;342/3|
00000000|MMI|14.80|Titrate|C1883350|[hlca]|["Titrate"-tx-15-"titrate"-verb-0,"Titrate"-tx-15-"titrating"-adj-0,"Titrate"-tx-11-"titrate"-verb-0]|TX|4249/7;4287/9;[3190/7],[3211/7]|
00000000|MMI|14.64|Ethanol|C0001962|[orch,phsu]|["ETOH"-tx-9-"etoh"-noun-0]|TX|2187/4|D02.033.375;x.x.x.x
00000000|MMI|14.64|Sudden death|C0011071|[patf]|["Death, Sudden"-tx-9-"sudden death"-noun-1]|TX|2293/12|C23.550.260.322
00000000|MMI|14.64|clopidogrel|C0070166|[orch,phsu]|["CLOPIDOGREL"-tx-3-"CLOPIDOGREL"-noun-0]|TX|411/11|x.x.x.x
00000000|MMI|14.61|Body Fluid Discharge|C0012621|[bdsu]|["Discharge"-tx-16-"DISCHARGE"-noun-0,"Discharge"-tx-15-"DISCHARGE"-noun-0,"Discharge"-tx-3-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|4455/9;4199/9;1002/9;39/9|
00000000|MMI|14.61|Discharge, body substance|C2926602|[bdsu]|["Discharge"-tx-16-"DISCHARGE"-noun-0,"Discharge"-tx-15-"DISCHARGE"-noun-0,"Discharge"-tx-3-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|4455/9;4199/9;1002/9;39/9|
00000000|MMI|14.50|Per Nanoliter|C3892223|[qnco]|["/nL"-tx-9-"nl"-noun-0,"/nL"-tx-7-"nL"-noun-0]|TX|[2717/2],[2725/2],[2736/2];1837/2|
00000000|MMI|14.50|nanolitre|C0560008|[qnco]|["nL"-tx-9-"nl"-noun-0,"nL"-tx-7-"nL"-noun-0]|TX|[2717/2],[2725/2],[2736/2];1837/2|
00000000|MMI|14.49|10%|C3842590|[fndg]|["10%"-tx-16-"10"-fraction-0,"10%"-tx-9-"10"-integer-0,"10%"-tx-4-"10"-integer-0,"10%"-tx-3-"10"-integer-0]|TX|4422/2;2106/2;1607/2;901/2|
00000000|MMI|13.35|Heart|C0018787|[bpoc]|["Cardiac"-tx-13-"cardiac"-adj-0,"Cardiac"-tx-3-"cardiac"-adj-0]|TX|3504/7;1311/7|A07.541
00000000|MMI|13.23|Dyspnea|C0013404|[sosy]|["SHORTNESS OF BREATH"-tx-14-"shortness of breath"-noun-0]|TX|4147/19|C08.618.326;C23.888.852.371
00000000|MMI|13.22|TACSTD1 protein, human|C0903677|[aapp,imft]|["TROP-1"-tx-9-"trop 1"-noun-0]|TX|2504/4,2515/1|x.x.x.x
00000000|MMI|13.14|Attention|C0004268|[menp]|["Attention"-tx-14-"attention"-noun-0]|TX|4087/9|F02.830.104.214
00000000|MMI|13.14|Urinary tract infection|C0042029|[dsyn]|["UTI"-tx-13-"UTI"-noun-0]|TX|3968/3|C01.539.895;C12.777.892;C13.351.968.892
00000000|MMI|13.14|urinastatin|C0077906|[aapp,phsu]|["UTI"-tx-13-"UTI"-noun-0]|TX|3968/3|x.x.x.x
00000000|MMI|13.09|Weight Bearing|C0085086|[fndg]|["Weight Bearing"-tx-3-"weight-bearing"-adj-0]|TX|781/14|G01.374.676.965;G01.595.540.965
00000000|MMI|13.09|Weight-Bearing state|C1318107|[orga]|["Weightbearing"-tx-3-"weight-bearing"-adj-0]|TX|781/14|G01.374.676.965;G01.595.540.965
00000000|MMI|13.05|4-azido-7-phenylpyrazolo-(1,5a)-1,3,5-triazine|C0245203|[bacs,orch]|["APPT"-tx-13-"appt"-noun-0]|TX|3641/4|x.x.x.x
00000000|MMI|13.00|Dilatation and Curettage|C0012358|[topp]|["D & C"-tx-1-"D/C"-noun-0]|TX|185/3|E04.157.310;E04.950.300.299
00000000|MMI|12.96|dioctadecylamidospermine|C0640640|[orch]|["1-DOS"-tx-3-"1 doses"-noun-0]|TX|660/1,678/5|x.x.x.x
00000000|MMI|12.96|Coronary heart disease|C0010068|[dsyn]|["Coronary (artery) disease"-tx-3-"coronary artery disease"-noun-0]|TX|968/23|C14.280.647.250;C14.907.585.250
00000000|MMI|12.96|Nausea|C0027497|[sosy]|["symptoms nausea"-tx-5-"symptoms nausea"-noun-0]|TX|1628/8,1658/6|C23.888.821.712
00000000|MMI|12.94|ACE protein, human|C1452534|[aapp,bacs]|["ACE"-tx-9-"ace"-noun-0]|TX|2140/3|x.x.x.x
00000000|MMI|12.94|In Urine|C0042037|[ftcn]|["URINE"-tx-9-"urine"-noun-0]|TX|2555/5|x.x.x.x
00000000|MMI|12.91|Gentamicin Sulfate (USP)|C0546866|[antb,orch]|["GM"-tx-3-"gm"-noun-0]|TX|700/2|D09.408.051.374
00000000|MMI|12.91|Smoking|C0037369|[inbe]|["SMOKING"-tx-14-"smoking"-noun-0]|TX|4022/7|F01.145.958.500
00000000|MMI|12.90|Automobiles|C0004381|[mnob]|["Car"-tx-1-"CAR"-noun-0]|TX|103/3|J01.937.500.100
00000000|MMI|12.37|Take|C1515187|[hlca]|["Take"-tx-13-"take"-verb-0,"Take"-tx-13-"taking"-verb-0,"Take"-tx-8-"took"-verb-0]|TX|3753/4;3882/6;1880/4|
00000000|MMI|11.79|Order (action)|C1705178|[acty]|["Order"-tx-16-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|4465/6;189/5;49/6|
00000000|MMI|11.79|Order (arrangement)|C1705176|[qlco]|["Order"-tx-16-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|4465/6;189/5;49/6|
00000000|MMI|11.79|Order (document)|C1705175|[inpr]|["Order"-tx-16-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|4465/6;189/5;49/6|
00000000|MMI|11.79|Order (taxonomic)|C1705177|[clas]|["Order"-tx-16-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|4465/6;189/5;49/6|
00000000|MMI|11.79|Permutation|C1882348|[qlco]|["Order"-tx-16-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|4465/6;189/5;49/6|
00000000|MMI|11.79|Sequence of Planned Assessment Schedule|C3889825|[inpr]|["ORDER"-tx-16-"ORDERS"-verb-0,"ORDER"-tx-1-"ORDER"-noun-0,"ORDER"-tx-1-"ORDERS"-verb-0]|TX|4465/6;189/5;49/6|
00000000|MMI|11.49|Allergy Specialty|C0002111|[bmod]|["Allergy"-tx-3-"ALLERGY"-noun-0]|TX|912/7|H02.403.044
00000000|MMI|11.49|Complication Aspects|C1171258|[patf]|["complications"-tx-3-"Complications"-noun-0]|TX|1133/13|x.x.x
00000000|MMI|11.49|Glaucoma|C0017601|[dsyn]|["GLAUCOMA"-tx-3-"glaucoma"-noun-0]|TX|1250/8|C11.525.381
00000000|MMI|11.49|Kidney|C0022646|[bpoc]|["Renal"-tx-13-"RENAL"-adj-0]|TX|3441/5|A05.810.453
00000000|MMI|11.49|Lawyer (occupation)|C0086530|[prog]|["ATTORNEY"-tx-9-"attorney"-noun-0]|TX|2229/8|M01.526.520
00000000|MMI|11.49|Methods aspects|C0025664|[inpr]|["procedures"-tx-3-"PROCEDURES"-noun-0]|TX|1295/10|x.x.x
00000000|MMI|11.49|Stent, device|C0038257|[medd]|["stented"-tx-9-"stented"-verb-0]|TX|2882/7|E07.695.750
00000000|MMI|11.30|R prime|C2603358|[clna]|["R'"-tx-12-"R"-noun-0,"R'"-tx-9-"r"-adj-0,"R'"-tx-3-"R"-noun-0]|TX|3246/1;2342/1;1363/1|
00000000|MMI|11.30|Right|C0205090|[spco]|["R-"-tx-12-"R"-noun-0,"R-"-tx-9-"r"-adj-0,"R-"-tx-3-"R"-noun-0]|TX|3246/1;2342/1;1363/1|
00000000|MMI|11.22|/40|C0439509|[tmco]|["/40"-tx-10-"40"-percentage-0,"/40"-tx-9-"40"-integer-0,"/40"-tx-9-"40"-percentage-0]|TX|3157/2;[2070/2],[2704/2];[2070/2],[2704/2]|
00000000|MMI|11.22|40%|C3842587|[qnco]|["40%"-tx-10-"40"-percentage-0,"40%"-tx-9-"40"-integer-0,"40%"-tx-9-"40"-percentage-0]|TX|3157/2;[2070/2],[2704/2];[2070/2],[2704/2]|
00000000|MMI|11.22|Percent in White Blood Count Differential|C1882326|[qnco]|["% WBC"-tx-13-"WBC"-noun-0,"% WBC"-tx-9-"WBC"-noun-0,"% WBC"-tx-9-"wbc"-noun-0]|TX|3396/3;2538/3;2477/3|
00000000|MMI|11.16|Myocardial Infarction ECG Assessment|C3810814|[diap]|["MI"-tx-9-"mi"-noun-0,"MI"-tx-5-"MI"-noun-0,"MI"-tx-3-"mi"-noun-0]|TX|1960/2;1621/2;1477/2|
00000000|MMI|11.01|20%|C3842589|[fndg]|["20%"-tx-9-"20"-integer-0,"20%"-tx-3-"20"-integer-0]|TX|2155/2;[464/2],[904/2]|
00000000|MMI|10.78|Not Applicable|C1272460|[qlco]|["{NA}"-tx-9-"Na"-noun-0,"{NA}"-tx-3-"Na"-noun-0,"NOT APPLICABLE"-tx-1-"Not Applicable"-adj-0]|TX|2250/2;703/2;165/14|
00000000|MMI|10.78|Package Type Not Applicable|C4049872|[ftcn]|["NA"-tx-9-"Na"-noun-0,"NA"-tx-3-"Na"-noun-0,"Not Applicable"-tx-1-"Not Applicable"-adj-0]|TX|2250/2;703/2;165/14|
00000000|MMI|10.61|Code|C0805701|[inpr]|["CODE"-tx-13-"CODE"-noun-0,"CODE"-tx-3-"CODE"-noun-0,"CODE"-tx-3-"code"-noun-0]|TX|3682/4;263/4;281/4|
00000000|MMI|10.61|eTMF Content Model Code|C3889831|[inpr]|["Code"-tx-13-"CODE"-noun-0,"Code"-tx-3-"CODE"-noun-0,"Code"-tx-3-"code"-noun-0]|TX|3682/4;263/4;281/4|
00000000|MMI|10.59|Sinus - general anatomical term|C1305231|[bsoj]|["SINUS"-tx-12-"sinus"-noun-0,"SINUS"-tx-9-"sinus"-noun-0]|TX|3258/5;[1936/5],[2613/5]|
00000000|MMI|10.59|Home environment|C0442519|[cnce]|["HOME"-tx-13-"home"-noun-0,"HOME"-tx-8-"home"-adj-0,"HOME"-tx-3-"Home"-noun-0]|TX|3597/4;1869/4;299/4|
00000000|MMI|10.56|Full|C0443225|[qlco]|["Full"-tx-13-"FULL"-adj-0,"Full"-tx-3-"Full"-adj-0]|TX|3677/4;[276/4],[776/4]|
00000000|MMI|10.42|3+ Answer to Question|C3838680|[fndg]|["3+"-tx-15-"3"-integer-0,"3+"-tx-14-"3"-integer-0]|TX|4329/1;4005/1|
00000000|MMI|10.42|3+ Score|C2827736|[qnco]|["3+"-tx-15-"3"-integer-0,"3+"-tx-14-"3"-integer-0]|TX|4329/1;4005/1|
00000000|MMI|10.42|3+ Score, WHO|C2981702|[clas]|["3+"-tx-15-"3"-integer-0,"3+"-tx-14-"3"-integer-0]|TX|4329/1;4005/1|
00000000|MMI|10.42|<3 (qualifier value)|C0439086|[qnco]|["<3"-tx-15-"3"-integer-0,"<3"-tx-14-"3"-integer-0]|TX|4329/1;4005/1|
00000000|MMI|10.42|Diagnosis|C0011900|[fndg]|["DIAGNOSIS"-tx-3-"DIAGNOSIS"-noun-0]|TX|[957/9],[1097/9]|E01
00000000|MMI|10.42|Diagnosis Study|C1704656|[resa]|["DIAGNOSIS"-tx-3-"DIAGNOSIS"-noun-0]|TX|[957/9],[1097/9]|
00000000|MMI|10.42|Doctor of Medicine|C1512018|[inpr]|["M.D."-tx-15-"M.D"-noun-0,"M.D."-tx-2-"M.D"-noun-0]|TX|4408/3;258/3|
00000000|MMI|10.42|Lipid panel|C0200382|[lbpr]|["Lipid panel"-tx-15-"lipid panel"-noun-0,"Lipid panel"-tx-9-"lipid panel"-noun-0]|TX|4340/11;3001/11|
00000000|MMI|10.42|Obesity Adverse Event|C1963185|[fndg]|["Obesity"-tx-9-"obesity"-noun-0,"Obesity"-tx-3-"obesity"-noun-0]|TX|1976/7;1228/7|
00000000|MMI|10.42|Schedule (document type)|C0086960|[inpr]|["Scheduled"-tx-13-"scheduled"-verb-0]|TX|[3739/9],[3815/9]|
00000000|MMI|10.42|Scheduled - priority|C1571999|[qlco]|["Scheduled"-tx-13-"scheduled"-verb-0]|TX|[3739/9],[3815/9]|
00000000|MMI|10.42|Scheduled - procedure status|C0205539|[qlco]|["Scheduled"-tx-13-"scheduled"-verb-0]|TX|[3739/9],[3815/9]|
00000000|MMI|10.42|consider|C0750591|[idcn]|["consider"-tx-15-"consider"-verb-0,"consider"-tx-9-"consider"-verb-0]|TX|4278/8;2976/8|
00000000|MMI|10.42|orders - HL7PublishingDomain|C3244315|[inpr]|["orders"-tx-16-"ORDERS"-verb-0,"orders"-tx-1-"ORDERS"-verb-0]|TX|4465/6;49/6|
00000000|MMI|9.99|Heart Atrium|C0018792|[bpoc]|["Atria"-tx-9-"atria"-noun-0]|TX|2728/5|A07.541.358
00000000|MMI|9.94|Appointments|C0003629|[idcn]|["Appointment"-tx-3-"APPOINTMENT"-noun-0]|TX|841/11|N04.452.095
00000000|MMI|9.91|Assisted Reproductive Technologies|C0872104|[topp]|["IVF"-tx-13-"ivf"-noun-0]|TX|3476/3|E02.875.800;E05.820.800
00000000|MMI|9.91|Tobacco|C0040329|[hops,orch,phsu]|["TOBACCO"-tx-9-"tobacco"-noun-0]|TX|2168/7|J01.637.836
00000000|MMI|9.88|enzymology|C0014445|[ftcn]|["enzymes"-tx-9-"enzymes"-noun-0]|TX|3027/7|x.x.x
00000000|MMI|9.87|Patient Monitoring|C0030695|[hlca]|["monitor"-tx-12-"monitor"-noun-0]|TX|3270/7|E01.370.520
00000000|MMI|9.85|Males|C0086582|[orga]|["MALE"-tx-3-"male"-noun-0]|TX|1453/4|x.x.x
00000000|MMI|9.78|Stenosis|C1261287|[patf]|["Stricture"-tx-3-"stricture"-noun-0]|TX|1270/9|C23.300.287
00000000|MMI|9.78|Urine|C0042036|[bdsu]|["URINE"-tx-9-"urine"-noun-0]|TX|2555/5|A12.207.927
00000000|MMI|9.76|Germany|C0017480|[geoa]|["GM"-tx-3-"gm"-noun-0]|TX|700/2|Z01.542.315;Z01.586.315
00000000|MMI|9.74|Abdomen|C0000726|[blor]|["abd"-tx-9-"abd"-adj-0]|TX|2433/3|A01.923.047
00000000|MMI|8.34|Allergic Reaction|C1527304|[patf]|["Allergy"-tx-3-"ALLERGY"-noun-0]|TX|912/7|C20.543
00000000|MMI|8.34|Electrolytes|C0013832|[inch,phsu]|["ELECTROLYTES"-tx-13-"electrolytes"-noun-0]|TX|3544/12|D01.248
00000000|MMI|8.34|Emotions|C0013987|[menp]|["feels"-tx-6-"feels"-verb-0]|TX|1686/5|F01.470
00000000|MMI|8.34|Hypersensitivity|C0020517|[patf]|["ALLERGY"-tx-3-"ALLERGY"-noun-0]|TX|912/7|C20.543
00000000|MMI|8.34|Infection|C3714514|[patf]|["Infections"-tx-3-"Infections"-noun-0]|TX|1120/10|C01.539
00000000|MMI|8.34|Maintenance|C0024501|[acty]|["Maintain"-tx-14-"maintain"-verb-0]|TX|4036/8|N02.628
00000000|MMI|8.00|Show|C1547282|[anim]|["Show"-tx-13-"showed"-verb-0,"Show"-tx-10-"showing"-verb-0]|TX|3386/6;3146/7|
00000000|MMI|7.70|Attending (action)|C1999232|[ftcn]|["attending"-tx-3-"Attending"-noun-0,"attending"-tx-1-"Attending"-noun-0]|TX|1406/9;227/9|
00000000|MMI|7.70|Attending (provider role)|C1547429|[prog]|["Attending"-tx-3-"Attending"-noun-0,"Attending"-tx-1-"Attending"-noun-0]|TX|1406/9;227/9|
00000000|MMI|7.70|Edema:Finding:Point in time:^Patient:Ordinal|C1717255|[clna]|["Edema"-tx-9-"edema"-noun-0,"Edema"-tx-6-"edema"-noun-0]|TX|2425/5;1752/5|
00000000|MMI|7.70|Nitrate|C0699857|[inch]|["Nitrate"-tx-10-"nitrate"-noun-0,"Nitrate"-tx-9-"nitrate"-noun-0]|TX|3106/7;2966/7|
00000000|MMI|7.70|P Blood group antibodies|C0369773|[aapp,imft]|["P NOS"-tx-10-"P"-noun-0,"P NOS"-tx-9-"p"-adj-0]|TX|3096/1;2323/1|
00000000|MMI|7.70|P prime|C2603361|[clna]|["P'"-tx-10-"P"-noun-0,"P'"-tx-9-"p"-adj-0]|TX|3096/1;2323/1|
00000000|MMI|7.70|Plain chest X-ray|C0039985|[diap]|["cxr"-tx-13-"cxr"-noun-0,"cxr"-tx-9-"CXR"-noun-0]|TX|3335/3;2597/3|
00000000|MMI|7.61|Condition|C0348080|[qlco]|["Condition"-tx-15-"CONDITION"-noun-0,"Condition"-tx-3-"Conditions"-noun-0]|TX|4209/9;1107/10|
00000000|MMI|7.61|Condition:Find:Pt:^Patient:Nom|C3864998|[clna]|["Condition"-tx-15-"CONDITION"-noun-0,"Condition"-tx-3-"Conditions"-noun-0]|TX|4209/9;1107/10|
00000000|MMI|7.61|Logical Condition|C1705253|[cnce]|["Condition"-tx-15-"CONDITION"-noun-0,"Condition"-tx-3-"Conditions"-noun-0]|TX|4209/9;1107/10|
00000000|MMI|7.55|Plavix|C0633084|[orch,phsu]|["Plavix"-tx-13-"plavix"-noun-0,"Plavix"-tx-3-"PLAVIX"-noun-0]|TX|3794/6;402/6|
00000000|MMI|7.54|Stop (Instruction Imperative)|C1947925|[acty]|["Stop"-tx-13-"stop"-verb-0,"Quit"-tx-9-"quit"-noun-0]|TX|3877/4;2176/4|
00000000|MMI|7.53|BESTROPHINOPATHY, AUTOSOMAL RECESSIVE|C3888198|[dsyn]|["ARB"-tx-15-"ARB"-noun-0,"ARB"-tx-9-"arb"-noun-0]|TX|4257/3;2985/3|
00000000|MMI|7.53|Echo (insect)|C1655045|[euka]|["Echo"-tx-10-"echo"-noun-0,"Echo"-tx-9-"ECHO"-noun-0]|TX|3132/4;2687/4|
00000000|MMI|7.53|Stop (qualifier value)|C2746065|[tmco]|["End"-tx-16-"END"-noun-0,"Stop"-tx-13-"stop"-verb-0]|TX|4448/3;3877/4|
00000000|MMI|7.49|Follow|C1719822|[inpr]|["Follow"-tx-15-"follow"-verb-0,"Follow"-tx-13-"follow"-verb-0]|TX|4333/6;3712/6|
00000000|MMI|7.49|Followed by|C0332283|[tmco]|["follow"-tx-15-"follow"-verb-0,"follow"-tx-13-"follow"-verb-0]|TX|4333/6;3712/6|
00000000|MMI|7.36|Pharmacogenomics Trial Characteristics Domain|C3714755|[inpr]|["PT"-tx-15-"pt's"-noun-0,"PT"-tx-13-"pt"-noun-0]|TX|4306/4;3417/2|
00000000|MMI|7.36|Physical therapy (field)|C0699718|[bmod]|["PT"-tx-15-"pt's"-noun-0,"PT"-tx-13-"pt"-noun-0]|TX|4306/4;3417/2|
00000000|MMI|7.31|Blood group antibody I|C0221138|[aapp,imft]|["I NOS"-tx-10-"i"-noun-0,"I NOS"-tx-9-"I"-noun-0]|TX|3121/1;2935/1|
00000000|MMI|7.31|Basal Diet|C2983588|[food]|["DIET"-tx-13-"diet"-noun-0,"DIET"-tx-3-"DIET"-noun-0]|TX|3512/4;684/4|
00000000|MMI|7.31|Diet (animal life circumstance)|C3668949|[food]|["Diet"-tx-13-"diet"-noun-0,"Diet"-tx-3-"DIET"-noun-0]|TX|3512/4;684/4|
00000000|MMI|7.31|Lesion|C0221198|[fndg]|["Lesion"-tx-9-"lesion"-noun-0]|TX|[2854/6],[2873/6]|
00000000|MMI|7.31|Special Diet Therapy|C1519433|[topp]|["DIET"-tx-13-"diet"-noun-0,"DIET"-tx-3-"DIET"-noun-0]|TX|3512/4;684/4|
00000000|MMI|7.31|Specimen Source Codes - Lesion|C1546698|[inpr]|["Lesion"-tx-9-"lesion"-noun-0]|TX|[2854/6],[2873/6]|
00000000|MMI|7.30|Admission activity|C0809949|[hlca]|["Admission"-tx-3-"Admission"-noun-0,"Admitted"-tx-3-"admitted"-verb-0]|TX|1059/9;1540/8|
00000000|MMI|7.29|Reduced|C0392756|[qlco]|["Reduced"-tx-13-"reduced"-verb-0,"Reduced"-tx-9-"reduced"-adj-0]|TX|3859/7;2762/7|
00000000|MMI|7.27|Today|C0310367|[antb,orch]|["Today"-tx-8-"today"-noun-0,"Today"-tx-3-"Today"-noun-0]|TX|1874/5;488/5|
00000000|MMI|7.27|Today (temporal qualifier)|C0750526|[tmco]|["Today"-tx-8-"today"-noun-0,"Today"-tx-3-"Today"-noun-0]|TX|1874/5;488/5|
00000000|MMI|7.27|Hospital course|C0489547|[fndg]|["Hospital course"-tx-9-"Hospital Course"-noun-0,"Hospital course"-tx-3-"HOSPITAL COURSE"-noun-1]|TX|2908/15;1389/15|
00000000|MMI|7.27|Hospital course:Finding:Point in time:^Patient:Narrative|C0488549|[clna]|["Hospital course"-tx-9-"Hospital Course"-noun-0,"Hospital course"-tx-3-"HOSPITAL COURSE"-noun-0]|TX|2908/15;1389/15|
00000000|MMI|7.26|HP gene|C1415692|[gngm]|["Bp"-tx-11-"BP"-noun-0,"Bp"-tx-9-"bp"-noun-0]|TX|3201/2;2330/2|
00000000|MMI|7.26|HP wt Allele|C1708288|[gngm]|["BP"-tx-11-"BP"-noun-0,"BP"-tx-9-"bp"-noun-0]|TX|3201/2;2330/2|
00000000|MMI|7.26|Summary (document)|C1706244|[inpr]|["Summary"-tx-15-"summary"-noun-0,"Summary"-tx-1-"SUMMARY"-noun-0]|TX|4368/7;214/7|
00000000|MMI|7.26|summary - ActRelationshipSubset|C1552616|[inpr]|["summary"-tx-15-"summary"-noun-0,"summary"-tx-1-"SUMMARY"-noun-0]|TX|4368/7;214/7|
00000000|MMI|7.24|Genus Lemmus (organism)|C0023295|[mamm]|["Lemmings"-tx-13-"lemmings"-noun-0,"Lemmings"-tx-3-"LEMMINGS"-noun-0]|TX|3727/8;866/8|
00000000|MMI|7.19|Planned|C1301732|[ftcn]|["Plan"-tx-15-"PLAN"-noun-0,"Plan"-tx-10-"plans"-noun-0]|TX|4239/4;3068/5|
00000000|MMI|7.19|Treatment Plan|C0599880|[inpr]|["Plan"-tx-15-"PLAN"-noun-0,"Plan"-tx-10-"plans"-noun-0]|TX|4239/4;3068/5|
00000000|MMI|7.16|Regular exercise (observable entity)|C0582191|[dora]|["Regular exercise"-tx-14-"regular exercise"-noun-0,"Regular exercise"-tx-3-"regular exercise"-noun-0]|TX|4045/16;759/16|
00000000|MMI|7.11|Infusion pump Alert priority PM|C4049155|[fndg]|["PM"-tx-16-"PM"-noun-0,"PM"-tx-1-"PM"-adj-0]|TX|4438/2;146/2|
00000000|MMI|7.11|Routine|C0205547|[qlco]|["Routine"-tx-13-"routine"-adj-0,"Routine"-tx-3-"routine"-adj-0]|TX|3327/7;1568/7|
00000000|MMI|7.08|Three times daily|C0556984|[tmco]|["TID"-tx-11-"TID"-noun-0,"TID"-tx-9-"tid"-noun-0]|TX|3180/3;2109/3|
00000000|MMI|7.08|three times a day at institution-specified times|C1610169|[tmco]|["TID"-tx-11-"TID"-noun-0,"TID"-tx-9-"tid"-noun-0]|TX|3180/3;2109/3|
00000000|MMI|7.08|Delayed Release Dosage Form|C1707664|[bodm]|["DR"-tx-13-"dr"-noun-0,"DR"-tx-3-"DR"-noun-0]|TX|3724/2;863/2|
00000000|MMI|7.08|Device to Subject Relationship Domain|C3540849|[inpr]|["DR"-tx-13-"dr"-noun-0,"DR"-tx-3-"DR"-noun-0]|TX|3724/2;863/2|
00000000|MMI|7.08|Doctor - Title|C2348314|[cnce]|["Dr."-tx-13-"dr"-noun-0,"Dr."-tx-3-"DR"-noun-0]|TX|3724/2;863/2|
00000000|MMI|7.04|Clear|C2963144|[qlco]|["Clear"-tx-9-"clear"-adj-0]|TX|[2408/5],[2602/5]|
00000000|MMI|7.04|Negative Surgical Margin|C1709157|[fndg]|["Clear"-tx-9-"clear"-adj-0]|TX|[2408/5],[2602/5]|
00000000|MMI|7.04|Subject Continuance|C2826258|[evnt]|["CONT"-tx-10-"cont"-noun-0,"CONT"-tx-9-"cont"-noun-0]|TX|3101/4;2940/4|
00000000|MMI|7.04|Curriculum Vitae|C1880201|[inpr]|["Resume"-tx-3-"RESUME"-noun-0,"Resume"-tx-3-"Resume"-noun-0]|TX|1379/6;752/6|
00000000|MMI|7.04|Resume - Remote control command|C1550028|[idcn]|["Resume"-tx-3-"RESUME"-noun-0,"Resume"-tx-3-"Resume"-noun-0]|TX|1379/6;752/6|
00000000|MMI|7.04|resume - DataOperation|C3242342|[ftcn]|["resume"-tx-3-"RESUME"-noun-0,"resume"-tx-3-"Resume"-noun-0]|TX|1379/6;752/6|
00000000|MMI|7.01|Cardiac - anatomy qualifier|C1522601|[spco]|["Cardiac"-tx-13-"cardiac"-adj-0,"Cardiac"-tx-3-"cardiac"-adj-0]|TX|3504/7;1311/7|
00000000|MMI|7.01|Shortened|C1282927|[qlco]|["short"-tx-13-"short"-adj-0,"brief"-tx-3-"BRIEF"-adj-0]|TX|3931/5;1373/5|
00000000|MMI|6.98|Leucovorin Calcium|C0731033|[orch,phsu,vita]|["LV"-tx-9-"LV"-noun-0]|TX|[2739/2],[2770/2]|
00000000|MMI|6.98|Liposome Vesicle|C1881413|[chvs]|["LV"-tx-9-"LV"-noun-0]|TX|[2739/2],[2770/2]|
00000000|MMI|6.92|Axial R|C3538806|[spco]|["Ra"-tx-9-"Ra"-noun-0,"Ra"-tx-9-"ra"-noun-0]|TX|2247/2;2349/2|
00000000|MMI|6.92|No Application Type|C1546968|[idcn]|["NA"-tx-9-"Na"-noun-0,"NA"-tx-3-"Na"-noun-0]|TX|2250/2;703/2|
00000000|MMI|6.92|Right arm|C4048756|[bpoc]|["RA"-tx-9-"Ra"-noun-0,"RA"-tx-9-"ra"-noun-0]|TX|2247/2;2349/2|
00000000|MMI|6.92|Sodium Cation|C0597484|[elii]|["Na+"-tx-9-"Na"-noun-0,"Na+"-tx-3-"Na"-noun-0]|TX|2250/2;703/2|
00000000|MMI|6.83|Lung|C0024109|[bpoc]|["LUNGS"-tx-9-"lungs"-noun-0]|TX|2414/5|A04.411
00000000|MMI|6.72|Enzymes|C0014442|[enzy,orch]|["ENZYMES"-tx-9-"enzymes"-noun-0]|TX|3027/7|D08.811
00000000|MMI|6.60|Future|C0016884|[tmco]|["Future"-tx-9-"future"-noun-0]|TX|2992/6|I01.320
00000000|MMI|5.18|Affecting|C0392760|[ftcn]|["Affecting"-tx-3-"affecting"-verb-0]|TX|1149/9|
00000000|MMI|5.18|Allergic disposition|C3539909|[dsyn]|["Allergy"-tx-3-"ALLERGY"-noun-0]|TX|912/7|
00000000|MMI|5.18|Allergy - Physicians|C1554743|[prog]|["Allergy"-tx-3-"ALLERGY"-noun-0]|TX|912/7|
00000000|MMI|5.18|Androgen Receptor Positive|C2986463|[fndg]|["AR+"-tx-9-"AR"-noun-1]|TX|2782/2|
00000000|MMI|5.18|CDISC Events Class|C3541888|[clas]|["EVENTS"-tx-12-"events"-noun-0]|TX|3290/6|
00000000|MMI|5.18|Cancer Genus|C0998265|[euka]|["Cancer"-tx-9-"cancer"-noun-0]|TX|2279/6|
00000000|MMI|5.18|Cardiovascular System Findings Domain|C3538987|[idcn]|["CV"-tx-9-"CV"-noun-0]|TX|2929/2|
00000000|MMI|5.18|Chest pain:Finding:Point in time:^Patient:Ordinal|C2926613|[clna]|["Chest pain"-tx-14-"chest pain"-noun-0]|TX|4109/10|
00000000|MMI|5.18|Chest pressure|C0438716|[sosy]|["Chest pressure"-tx-14-"chest pressure"-noun-0]|TX|4122/14|
00000000|MMI|5.18|Clipperton Island|C4050020|[geoa]|["CP"-tx-4-"cp"-noun-0]|TX|1590/2|
00000000|MMI|5.18|Complication|C0009566|[patf]|["Complications"-tx-3-"Complications"-noun-0]|TX|1133/13|
00000000|MMI|5.18|Digestive System Findings Domain|C3539617|[inpr]|["GI"-tx-13-"GI"-noun-0]|TX|3500/2|
00000000|MMI|5.18|Discharge date|C2361123|[tmco]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|5.18|Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2361122|[clna]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|5.18|Dizziness Adverse Event|C1963093|[fndg]|["Dizziness"-tx-6-"dizziness"-noun-1]|TX|1785/9|
00000000|MMI|5.18|Does walk|C0600108|[fndg]|["Walks"-tx-6-"walks"-verb-0]|TX|1699/5|
00000000|MMI|5.18|Electrolyte [EPC]|C3536863|[phsu]|["Electrolytes"-tx-13-"electrolytes"-noun-0]|TX|3544/12|
00000000|MMI|5.18|Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider}|C1316572|[clna]|["Note"-tx-13-"note"-verb-0]|TX|3826/4|
00000000|MMI|5.18|Event|C0441471|[evnt]|["Events"-tx-12-"events"-noun-0]|TX|3290/6|
00000000|MMI|5.18|Flat shape|C0205324|[spco]|["Flat"-tx-9-"flat"-adj-0]|TX|2525/4|
00000000|MMI|5.18|GNAI1 wt Allele|C1708130|[gngm]|["Gi"-tx-13-"GI"-noun-0]|TX|3500/2|
00000000|MMI|5.18|Gastrointestinal studies and measurements|C4050121|[inpr]|["GI"-tx-13-"GI"-noun-0]|TX|3500/2|
00000000|MMI|5.18|Glaucoma (eukaryote)|C0997768|[euka]|["Glaucoma"-tx-3-"glaucoma"-noun-0]|TX|1250/8|
00000000|MMI|5.18|Glaucoma Adverse Event|C1962986|[fndg]|["Glaucoma"-tx-3-"glaucoma"-noun-0]|TX|1250/8|
00000000|MMI|5.18|Good|C0205170|[qlco]|["Well"-tx-6-"well"-adv-0]|TX|1692/4|
00000000|MMI|5.18|IV medication|C1971835|[phsu]|["IV Drugs"-tx-9-"iv drugs"-noun-0]|TX|2200/8|
00000000|MMI|5.18|Identifier|C0600091|[inpr]|["ID"-tx-13-"ID"-noun-0]|TX|3378/2|
00000000|MMI|5.18|Immune diffusion|C1441613|[lbpr]|["ID"-tx-13-"ID"-noun-0]|TX|3378/2|
00000000|MMI|5.18|Including (qualifier)|C0332257|[ftcn]|["Including"-tx-13-"including"-verb-0]|TX|3784/9|
00000000|MMI|5.18|Increase|C0442805|[ftcn]|["increases"-tx-15-"increases"-verb-0]|TX|4319/9|
00000000|MMI|5.18|Increased|C0205217|[qnco]|["Increases"-tx-15-"increases"-verb-0]|TX|4319/9|
00000000|MMI|5.18|Infrequent|C0521114|[tmco]|["Rare"-tx-9-"rare"-adj-0]|TX|2192/4|
00000000|MMI|5.18|Instruction [Publication Type]|C0302828|[inpr]|["instructions"-tx-3-"Instructions"-noun-0]|TX|502/12|
00000000|MMI|5.18|Instructions|C1442085|[idcn]|["Instructions"-tx-3-"Instructions"-noun-0]|TX|502/12|
00000000|MMI|5.18|Instructions:Text:Point in time:^Patient:Narrative|C3263700|[clna]|["Instructions"-tx-3-"Instructions"-noun-0]|TX|502/12|
00000000|MMI|5.18|Interventional procedure|C0184661|[topp]|["PROCEDURES"-tx-3-"PROCEDURES"-noun-0]|TX|1295/10|
00000000|MMI|5.18|Involvement with|C1314939|[ftcn]|["Affecting"-tx-3-"affecting"-verb-0]|TX|1149/9|
00000000|MMI|5.18|Lives with wife|C2960190|[fndg]|["Lives with wife"-tx-9-"lives with wife"-noun-1]|TX|2211/15|
00000000|MMI|5.18|MYOTONIC DYSTROPHY 1|C3250443|[dsyn]|["DM"-tx-9-"dm"-noun-1]|TX|2288/2|
00000000|MMI|5.18|Malignant Neoplasms|C0006826|[neop]|["CANCER"-tx-9-"cancer"-noun-1]|TX|2279/6|
00000000|MMI|5.18|Medical History|C0262926|[fndg]|["PMH"-tx-9-"PMH"-noun-0]|TX|1931/3|
00000000|MMI|5.18|NPPA gene|C1417807|[gngm]|["PND"-tx-6-"pnd"-noun-0]|TX|1743/3|
00000000|MMI|5.18|Note (document)|C1317574|[inpr]|["Note"-tx-13-"note"-verb-0]|TX|3826/4|
00000000|MMI|5.18|On admission|C0457453|[tmco]|["On admission"-tx-9-"on admission"-adj-0]|TX|2309/12|
00000000|MMI|5.18|Orthopnea|C0085619|[sosy]|["Orthopnoea"-tx-6-"orthopnea"-noun-1]|TX|1731/9|
00000000|MMI|5.18|PPP4C gene|C1418850|[gngm]|["PPX"-tx-13-"ppx"-noun-0]|TX|3574/3|
00000000|MMI|5.18|Palpitations|C0030252|[fndg]|["PALPITATIONS"-tx-6-"palpitations"-noun-1]|TX|1760/12|
00000000|MMI|5.18|Palpitations Adverse Event|C3160712|[fndg]|["Palpitations"-tx-6-"palpitations"-noun-1]|TX|1760/12|
00000000|MMI|5.18|Paroxysmal nocturnal dyspnea|C1956415|[dsyn]|["PND"-tx-6-"pnd"-noun-1]|TX|1743/3|
00000000|MMI|5.18|Patient in hospital|C0701159|[fndg]|["HOSPITALIZED"-tx-12-"hospitalized"-verb-1]|TX|3303/12|
00000000|MMI|5.18|Positive|C1446409|[qlco]|["ruled"-tx-9-"ruled"-verb-0]|TX|3014/5|
00000000|MMI|5.18|Presentation|C0449450|[idcn]|["Presented"-tx-3-"presented"-verb-0]|TX|1484/9|
00000000|MMI|5.18|Primary malignant neoplasm|C1306459|[neop]|["Cancer"-tx-9-"cancer"-noun-1]|TX|2279/6|
00000000|MMI|5.18|Procedure (set of actions)|C2700391|[acty]|["Procedures"-tx-3-"PROCEDURES"-noun-0]|TX|1295/10|
00000000|MMI|5.18|Pulmonary ventilator management|C1315068|[hlca]|["PULM"-tx-13-"PULM"-adj-0]|TX|3321/4|
00000000|MMI|5.18|Rare|C0522498|[qlco]|["Rare"-tx-9-"rare"-adj-0]|TX|2192/4|
00000000|MMI|5.18|Residential flat|C0457933|[mnob]|["Flat"-tx-9-"flat"-adj-0]|TX|2525/4|
00000000|MMI|5.18|Response to antigens|C1314973|[phsf]|["ALLERGY"-tx-3-"ALLERGY"-noun-0]|TX|912/7|
00000000|MMI|5.18|Retinoic Acid Response Element|C1514917|[gngm]|["RARE"-tx-9-"rare"-adj-0]|TX|2192/4|
00000000|MMI|5.18|S prime|C2603362|[clna]|["S'"-tx-3-"("-noun-0]|TX|852/1|
00000000|MMI|5.18|Scientific Study|C0947630|[lbpr]|["studies"-tx-9-"STUDIES"-noun-0]|TX|2588/7|
00000000|MMI|5.18|See|C1947903|[acty]|["See"-tx-9-"see"-verb-0]|TX|3052/3|
00000000|MMI|5.18|Since|C1711239|[tmco]|["Since"-tx-6-"Since"-adv-0]|TX|1675/5|
00000000|MMI|5.18|Sudden Death Adverse Event Not Associated with More Specific CTCAE Term|C1964022|[fndg]|["Sudden death"-tx-9-"sudden death"-noun-1]|TX|2293/12|
00000000|MMI|5.18|Syncope (amphibian)|C3541349|[amph]|["Syncope"-tx-6-"syncope"-noun-0]|TX|1775/7|
00000000|MMI|5.18|TCAP gene|C1420621|[gngm]|["TELE"-tx-12-"tele"-noun-0]|TX|3251/4|
00000000|MMI|5.18|Table Frame - above|C1552828|[idcn]|["above"-tx-9-"above"-adj-0]|TX|3056/5|
00000000|MMI|5.18|Telephone Number|C1515258|[cnce]|["Tele"-tx-12-"tele"-noun-0]|TX|3251/4|
00000000|MMI|5.18|Then|C1883708|[tmco]|["Then"-tx-6-"then"-adv-0]|TX|1681/4|
00000000|MMI|5.18|Upper|C1282910|[spco]|["Above"-tx-9-"above"-adj-0]|TX|3056/5|
00000000|MMI|5.18|Well|C3146287|[mnob]|["Well"-tx-6-"well"-adv-0]|TX|1692/4|
00000000|MMI|5.18|atorvastatin|C0286651|[orch,phsu]|["ATORVASTATIN"-tx-3-"ATORVASTATIN"-noun-0]|TX|372/12|
00000000|MMI|5.18|per second|C0565930|[qnco]|["/s"-tx-3-"("-noun-0]|TX|852/1|
00000000|MMI|5.18|treatments and procedures|C0237403|[topp]|["treatments procedures"-tx-3-"TREATMENTS/PROCEDURES"-noun-0]|TX|1330/21|
00000000|MMI|3.77|Shortness of breath:-:Point in time:^Patient:-|C2707305|[clna]|["Shortness of breath"-tx-14-"shortness of breath"-noun-0]|TX|4147/19|
00000000|MMI|3.75|Medication.discharge|C0806915|[fndg]|["Discharge medications"-tx-3-"DISCHARGE MEDICATIONS"-noun-0]|TX|304/21|
00000000|MMI|3.73|Domestic activities|C0441660|[dora]|["house activity"-tx-3-"House ACTIVITY"-noun-0]|TX|690/5,742/8|
00000000|MMI|3.68|AMBP gene|C1412376|[gngm]|["UTI"-tx-13-"UTI"-noun-0]|TX|3968/3|
00000000|MMI|3.68|Additional comments|C1830770|[fndg]|["Additional comments"-tx-13-"ADDITIONAL COMMENTS"-noun-0]|TX|3687/19|
00000000|MMI|3.68|Asymptomatic|C0231221|[fndg]|["Asymptomatic"-tx-13-"asymptomatic"-adj-0]|TX|3424/12|
00000000|MMI|3.68|Both cardiac atria|C0524422|[bpoc]|["atria"-tx-9-"atria"-noun-0]|TX|2728/5|
00000000|MMI|3.68|Creatinine finding|C1561535|[fndg]|["Creatinine"-tx-13-"creatinine"-noun-0]|TX|3454/10|
00000000|MMI|3.68|Integrated Neuromusculoskeletal Release|C1704538|[topp]|["INR"-tx-9-"inr"-noun-0]|TX|2496/3|
00000000|MMI|3.68|Low Mitosis-Karyorrhexis Index|C3890211|[qnco]|["Low"-tx-11-"low"-adj-0]|TX|3239/3|
00000000|MMI|3.68|MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME|C3280240|[dsyn]|["MEDS"-tx-9-"MEDS"-noun-0]|TX|2038/4|
00000000|MMI|3.68|Randomization Validation|C3889272|[resa]|["RV"-tx-9-"RV"-noun-0]|TX|2720/2|
00000000|MMI|3.68|Status|C0449438|[qlco]|["Status"-tx-3-"STATUS"-noun-0]|TX|268/6|
00000000|MMI|3.68|Symptoms|C1457887|[sosy]|["SYMPTOMS"-tx-14-"symptoms"-noun-0]|TX|4189/8|
00000000|MMI|3.68|Symptoms aspect|C0683368|[ftcn]|["symptoms"-tx-14-"symptoms"-noun-0]|TX|4189/8|
00000000|MMI|3.68|TXNRD1 wt Allele|C3811249|[gngm]|["TR"-tx-9-"TR"-noun-0]|TX|2793/2|
00000000|MMI|3.68|TXNRD2 wt Allele|C3811250|[gngm]|["TR"-tx-9-"TR"-noun-0]|TX|2793/2|
00000000|MMI|3.68|Thioredoxin Reductase 1, Cytoplasmic|C3814410|[aapp,enzy]|["TR"-tx-9-"TR"-noun-0]|TX|2793/2|
00000000|MMI|3.68|Tumor Results Domain|C3814152|[inpr]|["TR"-tx-9-"TR"-noun-0]|TX|2793/2|
00000000|MMI|3.68|low|C0205251|[qlco]|["Low"-tx-11-"low"-adj-0]|TX|3239/3|
00000000|MMI|3.68|low confidentiality|C1550472|[inpr]|["low"-tx-11-"low"-adj-0]|TX|3239/3|
00000000|MMI|3.68|low exposure|C4048187|[qlco]|["low"-tx-11-"low"-adj-0]|TX|3239/3|
00000000|MMI|3.68|prostate infection|C0240811|[dsyn]|["PROSTATE INFECTION"-tx-13-"prostate infection"-noun-0]|TX|3985/18|
00000000|MMI|3.65|Principal Diagnosis:-:Point in time:^Patient:-|C2598194|[clna]|["Principal Diagnosis"-tx-3-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|992/9,1012/9|
00000000|MMI|3.65|Principal diagnosis|C0332137|[qlco]|["Principal Diagnosis"-tx-3-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|992/9,1012/9|
00000000|MMI|3.64|Entered|C1521975|[qlco]|["Entered"-tx-15-"ENTERED"-verb-0]|TX|4376/7|
00000000|MMI|3.63|65|C0450385|[inpr]|["65"-tx-9-"65"-fraction-0]|TX|2337/2|
00000000|MMI|3.63|65+|C3843765|[fndg]|["65+"-tx-9-"65"-fraction-0]|TX|2337/2|
00000000|MMI|3.63|ActInformationPrivacyReason <operations>|C3244305|[ftcn]|["operations"-tx-3-"OPERATIONS"-noun-0]|TX|1280/10|
00000000|MMI|3.63|Anterior Myocardial Infarction by ECG Finding|C3536746|[fndg]|["Anterior MI"-tx-3-"anterior MI"-noun-0]|TX|1178/11|
00000000|MMI|3.63|Creatinine measurement|C0201975|[lbpr]|["CREAT"-tx-9-"creat"-noun-0]|TX|2465/5|
00000000|MMI|3.63|DNLZ gene|C2239359|[gngm]|["HEP"-tx-13-"hep"-noun-0]|TX|3579/3|
00000000|MMI|3.63|Disposition|C0743223|[idcn]|["Disposition"-tx-3-"DISPOSITION"-noun-0]|TX|286/11|
00000000|MMI|3.63|Disposition Domain|C1705555|[inpr]|["Disposition"-tx-3-"DISPOSITION"-noun-0]|TX|286/11|
00000000|MMI|3.63|HL7PublishingSubSection <operations>|C3244306|[inpr]|["operations"-tx-3-"OPERATIONS"-noun-0]|TX|1280/10|
00000000|MMI|3.63|HPSE wt Allele|C1705569|[gngm]|["HEP"-tx-13-"hep"-noun-0]|TX|3579/3|
00000000|MMI|3.63|Histamine Equivalent Prick Unit|C3891156|[qnco]|["HEP"-tx-13-"hep"-noun-0]|TX|3579/3|
00000000|MMI|3.63|Issue (document)|C1706387|[inpr]|["Issue"-tx-13-"issues"-noun-0]|TX|3354/6|
00000000|MMI|3.63|Pack years|C1277691|[inpr]|["Pack Year"-tx-9-"pack year"-noun-0]|TX|2158/9|
00000000|MMI|3.63|Problem|C0033213|[fndg]|["Issue"-tx-13-"issues"-noun-1]|TX|3354/6|
00000000|MMI|3.63|Saint Helena Islands|C0038108|[geoa]|["SH"-tx-9-"SH"-noun-0]|TX|2151/2|
00000000|MMI|3.63|Twenty Pack|C2700095|[qnco]|["20 Pack"-tx-9-"20 pack"-noun-0]|TX|2155/7|
00000000|MMI|3.63|Weight-bearing:-:Point in time:^Patient:-|C2598162|[clna]|["Weight-bearing"-tx-3-"weight-bearing"-adj-0]|TX|781/14|
00000000|MMI|3.63|discharge diagnosis|C1555319|[fndg]|["Discharge diagnosis"-tx-3-"DISCHARGE DIAGNOSIS"-noun-0]|TX|1002/19|
00000000|MMI|3.63|size|C0456389|[spco]|["Size"-tx-9-"size"-noun-0]|TX|2742/4|
00000000|MMI|3.61|Device Component System|C1704459|[mnob]|["System"-tx-9-"system"-noun-0]|TX|2839/6|
00000000|MMI|3.61|Negative - answer|C3853545|[qlco]|["NEG"-tx-9-"neg"-noun-0]|TX|2509/3|
00000000|MMI|3.61|Probable diagnosis|C0332148|[qlco]|["Likely"-tx-13-"likely"-adv-0]|TX|3614/6|
00000000|MMI|3.61|Probably|C0750492|[idcn]|["Likely"-tx-13-"likely"-adv-0]|TX|3614/6|
00000000|MMI|3.61|Regimen - CHV concept|C2945654|[inpr]|["regimen"-tx-14-"regimen"-noun-0]|TX|4062/7|
00000000|MMI|3.61|System|C0449913|[ftcn]|["System"-tx-9-"system"-noun-0]|TX|2839/6|
00000000|MMI|3.61|System - kit|C1553451|[mnob]|["System"-tx-9-"system"-noun-0]|TX|2839/6|
00000000|MMI|3.60|FXN gene|C1414812|[gngm]|["FXN"-tx-9-"fxn"-noun-0]|TX|2773/3|
00000000|MMI|3.60|During values|C0347985|[tmco]|["Peri"-tx-13-"peri"-adj-0]|TX|3486/4|
00000000|MMI|3.60|QUIT|C0748223|[idcn]|["QUIT"-tx-9-"quit"-noun-0]|TX|2176/4|
00000000|MMI|3.60|SCN5A gene|C1419864|[gngm]|["IVF"-tx-13-"ivf"-noun-0]|TX|3476/3|
00000000|MMI|3.60|Started|C1272689|[qlco]|["Started"-tx-11-"started"-adj-0]|TX|3162/7|
00000000|MMI|3.60|per year|C0439508|[tmco]|["/Year"-tx-9-"year"-noun-0]|TX|2163/4|
00000000|MMI|3.60|year|C0439234|[tmco]|["YEAR"-tx-9-"year"-noun-0]|TX|2163/4|
00000000|MMI|3.60|10 - 12|C3843787|[fndg]|["10 - 12"-tx-1-"10 12"-fraction-0]|TX|129/2,140/2|
00000000|MMI|3.60|Bactrim DS|C1154231|[orch,phsu]|["Bactrim DS"-tx-3-"BACTRIM DS"-noun-0]|TX|608/10|
00000000|MMI|3.59|ActInformationPrivacyReason <service>|C3245478|[idcn]|["service"-tx-1-"Service"-noun-0]|TX|94/7|
00000000|MMI|3.59|Services|C0557854|[ocac]|["Service"-tx-1-"Service"-noun-0]|TX|94/7|
00000000|MMI|3.59|Software Service|C2825316|[mnob]|["Service"-tx-1-"Service"-noun-0]|TX|94/7|
00000000|MMI|3.59|day|C0439228|[tmco]|["DAYS"-tx-5-"days"-noun-0]|TX|1669/4|
00000000|MMI|3.59|End|C0444930|[spco]|["End"-tx-16-"END"-noun-0]|TX|4448/3|
00000000|MMI|3.59|Medical Examination|C0582103|[hlca]|["Exam"-tx-9-"exam"-noun-0]|TX|2352/4|
00000000|MMI|3.59|Responsible to|C1273518|[fndg]|["Responsible"-tx-3-"Responsible"-adj-0]|TX|1023/11|
00000000|MMI|3.59|Total Amyloid Precursor Protein Measurement|C3887695|[lbpr]|["APPT"-tx-13-"appt"-noun-0]|TX|3641/4|
00000000|MMI|3.57|Changed status|C0443172|[qnco]|["changes"-tx-3-"changes"-verb-0]|TX|1557/7|
00000000|MMI|3.57|Changing|C0392747|[ftcn]|["changes"-tx-3-"changes"-verb-0]|TX|1557/7|
00000000|MMI|3.57|Conditional|C1701901|[qlco]|["Contingent"-tx-1-"CONTINGENT"-noun-0]|TX|149/10|
00000000|MMI|3.57|Delta (difference)|C1705241|[qnco]|["Change"-tx-3-"changes"-verb-0]|TX|1557/7|
00000000|MMI|3.57|ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS|C3540048|[enzy,phsu]|["ENZYMES"-tx-9-"enzymes"-noun-0]|TX|3027/7|
00000000|MMI|3.57|Enzymes FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM|C3540772|[enzy,phsu]|["Enzymes"-tx-9-"enzymes"-noun-0]|TX|3027/7|
00000000|MMI|3.57|Enzymes for ALIMENTARY TRACT AND METABOLISM|C3542456|[enzy,phsu]|["Enzymes"-tx-9-"enzymes"-noun-0]|TX|3027/7|
00000000|MMI|3.57|Enzymes, antithrombotic|C3541394|[enzy,phsu]|["Enzymes"-tx-9-"enzymes"-noun-0]|TX|3027/7|
00000000|MMI|3.57|Enzymes, hematological|C3540017|[enzy,phsu]|["Enzymes"-tx-9-"enzymes"-noun-0]|TX|3027/7|
00000000|MMI|3.57|Enzymes, peripheral vasodilators|C3540790|[enzy,phsu]|["Enzymes"-tx-9-"enzymes"-noun-0]|TX|3027/7|
00000000|MMI|3.57|Medications:-:Point in time:^Patient:-|C2598133|[clna]|["Medications"-tx-13-"medications"-noun-0]|TX|3770/11|
00000000|MMI|3.57|Medications:Presence or Identity:Duration of the study:^Patient:Nominal|C0802604|[clna]|["Medications"-tx-13-"medications"-noun-0]|TX|3770/11|
00000000|MMI|3.57|Negation|C1518422|[ftcn]|["Not"-tx-3-"NOT"-adv-0]|TX|1354/3|
00000000|MMI|3.57|Out (direction)|C0439787|[spco]|["Out"-tx-9-"out"-adv-0]|TX|3020/3|
00000000|MMI|3.57|Pharmaceutical Preparations|C0013227|[phsu]|["Medications"-tx-13-"medications"-noun-0]|TX|3770/11|D26
00000000|MMI|3.57|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-13-"PUO"-noun-1]|TX|3370/3|
00000000|MMI|3.57|Removed|C0849355|[qlco]|["Out"-tx-9-"out"-adv-0]|TX|3020/3|
00000000|MMI|3.57|Substitution - ActClass|C1555721|[idcn]|["Substitution"-tx-3-"Substitution"-noun-0]|TX|516/12|
00000000|MMI|3.57|Substitution - change|C1706204|[acty]|["Substitution"-tx-3-"Substitution"-noun-0]|TX|516/12|
00000000|MMI|3.56|Biomedical Monitors|C0181904|[medd]|["Monitor"-tx-12-"monitor"-noun-0]|TX|3270/7|
00000000|MMI|3.56|Empty (qualifier)|C1880497|[qlco]|["Free"-tx-4-"free"-adj-0]|TX|1593/4|
00000000|MMI|3.56|Free (available (qualifier))|C1996904|[qlco]|["Free"-tx-4-"free"-adj-0]|TX|1593/4|
00000000|MMI|3.56|Free of (attribute)|C0332296|[ftcn]|["free"-tx-4-"free"-adj-0]|TX|1593/4|
00000000|MMI|3.56|Laboratory test finding|C0587081|[fndg]|["Labs"-tx-9-"Labs"-noun-1]|TX|2450/4|
00000000|MMI|3.56|Monitor Device Component|C1704646|[mnob]|["Monitor"-tx-12-"monitor"-noun-0]|TX|3270/7|
00000000|MMI|3.56|Monitor, occupation|C1521743|[prog]|["Monitor"-tx-12-"monitor"-noun-0]|TX|3270/7|
00000000|MMI|3.56|Monitoring Device|C0596972|[medd]|["Monitor"-tx-12-"monitor"-noun-0]|TX|3270/7|
00000000|MMI|3.56|Preventive monitoring|C0150369|[hlca]|["monitor"-tx-12-"monitor"-noun-0]|TX|3270/7|
00000000|MMI|3.55|Course|C0750729|[tmco]|["Course"-tx-13-"course"-noun-0]|TX|3948/6|
00000000|MMI|3.55|Short|C1806781|[qnco]|["Short"-tx-13-"short"-adj-0]|TX|3931/5|
00000000|MMI|3.55|Short Value|C2350002|[qnco]|["Short"-tx-13-"short"-adj-0]|TX|3931/5|
00000000|MMI|3.55|Son (person)|C0037683|[famg]|["Son"-tx-9-"son"-noun-0]|TX|2240/3|
00000000|MMI|3.55|Used by|C1273517|[fndg]|["used"-tx-1-"USED"-verb-1]|TX|198/4|
00000000|MMI|3.54|Male Gender, Self Report|C1706180|[qlco]|["Male"-tx-3-"male"-noun-0]|TX|1453/4|
00000000|MMI|3.54|Male Phenotype|C1706428|[qlco]|["Male"-tx-3-"male"-noun-0]|TX|1453/4|
00000000|MMI|3.54|Male, Self-Reported|C1706429|[orga]|["Male"-tx-3-"male"-noun-0]|TX|1453/4|
00000000|MMI|3.53|Clinical Study Follow-up|C3274571|[hlca]|["FOLLOW-UP"-tx-3-"FOLLOW UP"-adj-0]|TX|831/9|
00000000|MMI|3.53|Discontinued|C1444662|[fndg]|["D/C"-tx-1-"D/C"-noun-1]|TX|185/3|
00000000|MMI|3.53|Doctor of Chiropractic|C1512015|[inpr]|["D.C."-tx-1-"D/C"-noun-0]|TX|185/3|
00000000|MMI|3.53|Follow-Up Report|C1704685|[inpr]|["Follow-Up"-tx-3-"FOLLOW UP"-adj-0]|TX|831/9|
00000000|MMI|3.53|Follow-up status|C0589120|[fndg]|["Follow-up"-tx-3-"FOLLOW UP"-adj-0]|TX|831/9|
00000000|MMI|3.53|follow-up|C1522577|[hlca]|["Follow Up"-tx-3-"FOLLOW UP"-adj-0]|TX|831/9|
00000000|MMI|3.50|Before|C0332152|[tmco]|["Prior"-tx-5-"Prior"-adj-0]|TX|1615/5|
00000000|MMI|3.50|C-Circle|C3538933|[celc]|["CC"-tx-3-"CC"-noun-0]|TX|1438/2|
00000000|MMI|3.50|Causing|C0678227|[ftcn]|["Causing"-tx-3-"Causing"-adj-0]|TX|1051/7|
00000000|MMI|3.50|Diagnosis Type - Final|C1546485|[idcn]|["Final"-tx-1-"FINAL"-adj-0]|TX|33/5|
00000000|MMI|3.50|Distant|C0443203|[spco]|["DISTANT"-tx-9-"distant"-adj-0]|TX|2389/7|
00000000|MMI|3.50|End-stage|C0205088|[qlco]|["Final"-tx-1-"FINAL"-adj-0]|TX|33/5|
00000000|MMI|3.50|Final|C3853528|[tmco]|["Final"-tx-1-"FINAL"-adj-0]|TX|33/5|
00000000|MMI|3.50|HPS4 gene|C1423767|[gngm]|["LE"-tx-6-"le"-adj-0]|TX|1749/2|
00000000|MMI|3.50|LE, Rat Strain|C2697858|[mamm]|["LE"-tx-6-"le"-adj-0]|TX|1749/2|
00000000|MMI|3.50|Less Than or Equal to|C0439090|[qnco]|["LE"-tx-6-"le"-adj-0]|TX|1749/2|
00000000|MMI|3.50|Medical|C0205476|[ftcn]|["Medical"-tx-14-"medical"-adj-0]|TX|4079/7|
00000000|MMI|3.50|Medical service|C0199168|[hlca]|["Medical"-tx-14-"medical"-adj-0]|TX|4079/7|
00000000|MMI|3.50|Minimum|C1524031|[qlco]|["Trace"-tx-9-"trace"-noun-0]|TX|2787/5|
00000000|MMI|3.50|Possible|C0332149|[qlco]|["Possible"-tx-13-"possible"-adj-0]|TX|3959/8|
00000000|MMI|3.50|Possible diagnosis|C2362652|[qlco]|["Possible"-tx-13-"possible"-adj-0]|TX|3959/8|
00000000|MMI|3.50|Possibly Related to Intervention|C1705910|[qlco]|["Possible"-tx-13-"possible"-adj-0]|TX|3959/8|
00000000|MMI|3.50|Prior Medication Usage|C2826257|[evnt]|["PRIOR"-tx-5-"Prior"-adj-0]|TX|1615/5|
00000000|MMI|3.50|Quantity limited request - Records|C1548330|[idcn]|["Records"-tx-7-"records"-noun-0]|TX|1845/7|
00000000|MMI|3.50|Query Quantity Unit - Records|C1553414|[qlco]|["Records"-tx-7-"records"-noun-0]|TX|1845/7|
00000000|MMI|3.50|Recent|C0332185|[tmco]|["Recent"-tx-6-"recent"-adj-0]|TX|1800/6|
00000000|MMI|3.50|ST Waveform Analysis|C2985331|[diap]|["STAN"-tx-1-"STAN"-noun-0]|TX|248/4|
00000000|MMI|3.50|Sequence Chromatogram|C1883002|[ftcn]|["Trace"-tx-9-"trace"-noun-0]|TX|2787/5|
00000000|MMI|3.50|Yes (indicator)|C1705108|[cnce]|["YES"-tx-1-"YES"-noun-0]|TX|223/3|
00000000|MMI|3.50|Yes - Yes/no indicator|C1549445|[idcn]|["Yes"-tx-1-"YES"-noun-0]|TX|223/3|
00000000|MMI|3.50|acute|C0205178|[tmco]|["ACUTE"-tx-13-"acute"-adj-0]|TX|3348/5|
00000000|MMI|3.50|dictated - DocumentCompletion|C1609990|[idcn]|["Dictated"-tx-15-"dictated"-adj-0]|TX|4359/8|
00000000|MMI|3.50|dictated - ParticipationMode|C1548384|[ftcn]|["dictated"-tx-15-"dictated"-adj-0]|TX|4359/8|
00000000|MMI|3.50|low grade|C1282907|[qlco]|["Low Grade"-tx-13-"low-grade"-adj-0]|TX|3975/9|
00000000|MMI|3.50|trace amount|C0442822|[qnco]|["Trace"-tx-9-"trace"-noun-0]|TX|2787/5|
00000000|MMI|3.50|trend|C1521798|[tmco]|["Trend"-tx-13-"trend"-noun-0]|TX|3448/5|
00000000|MMI|3.49|AB/Tubingen Zebrafish|C2700319|[fish]|["TAB-14"-tx-3-"TAB 14"-noun-0]|TX|662/3,675/2|
00000000|MMI|3.48|Low cholesterol|C0860920|[fndg]|["Low cholesterol"-tx-3-"Low cholesterol"-adj-0]|TX|708/3,730/11|
00000000|MMI|3.48|Concern|C2699424|[idcn]|["Concern"-tx-14-"concerning"-adj-0]|TX|4178/10|
00000000|MMI|3.48|100%|C3817553|[qnco]|["100%"-tx-9-"100"-integer-0]|TX|2053/3|
00000000|MMI|3.48|At|C1516077|[spco]|["At"-tx-8-"At"-adj-0]|TX|1866/2|
00000000|MMI|3.48|GATM wt Allele|C4049625|[gngm]|["AT"-tx-8-"At"-adj-0]|TX|1866/2|
00000000|MMI|3.48|Organ Measurement Domain|C1705272|[inpr]|["OM"-tx-9-"OM"-noun-0]|TX|2851/2|
00000000|MMI|3.48|Poor - grade value|C0542537|[qlco]|["Poor"-tx-9-"poor"-adj-0]|TX|2627/4|
00000000|MMI|3.48|Poor - qualifier|C2700379|[qlco]|["Poor"-tx-9-"poor"-adj-0]|TX|2627/4|
00000000|MMI|3.48|Portion of urine|C2963137|[bdsu]|["Urine"-tx-9-"urine"-noun-0]|TX|2555/5|
00000000|MMI|3.48|Post|C0687676|[tmco]|["Post"-tx-13-"post"-noun-0]|TX|3602/4|
00000000|MMI|3.48|Post Device Component|C1704687|[mnob]|["Post"-tx-13-"post"-noun-0]|TX|3602/4|
00000000|MMI|3.48|history of - * (non-specific)|C0455483|[fndg]|["h o"-tx-3-"h/o"-noun-0]|TX|1174/3|
00000000|MMI|3.47|Circle Unit of Plane Angle|C2347774|[qnco]|["circ"-tx-9-"circ"-noun-0]|TX|2834/4|
00000000|MMI|3.47|Circumference|C0332520|[qnco]|["Circ"-tx-9-"circ"-noun-0]|TX|2834/4|
00000000|MMI|3.47|Dominant|C1527180|[ftcn]|["Dominant"-tx-9-"dominant"-adj-0]|TX|2823/8|
00000000|MMI|3.47|Endocrine System Findings Domain|C3538926|[idcn]|["ED"-tx-8-"ED"-noun-0]|TX|1899/2|
00000000|MMI|3.47|LRPAP1 gene|C1416920|[gngm]|["RAP"-tx-9-"RAP"-noun-0]|TX|2805/3|
00000000|MMI|3.47|Patient activity scale|C3854028|[inpr]|["PAS"-tx-9-"PAS"-noun-0]|TX|2798/3|
00000000|MMI|3.47|Satisfactory - Patient Condition Code|C1547307|[inpr]|["Satisfactory"-tx-15-"Satisfactory"-adj-0]|TX|4220/12|
00000000|MMI|3.47|Sufficient|C0205410|[qlco]|["Satisfactory"-tx-15-"Satisfactory"-adj-0]|TX|4220/12|
00000000|MMI|3.47|pre-autophagosomal structure|C1820373|[celc]|["PAS"-tx-9-"PAS"-noun-0]|TX|2798/3|
00000000|MMI|3.46|irbesartan 75 MG|C0986851|[clnd]|["irbesartan 75 MG"-tx-3-"IRBESARTAN 75 MG"-noun-0]|TX|558/16|
00000000|MMI|3.46|80%|C3842583|[fndg]|["80%"-tx-3-"80"-integer-0]|TX|387/2|
00000000|MMI|3.46|Borg Category-Ratio 10 Perceived Exertion Score 3|C4049706|[inpr]|["Moderate"-tx-9-"moderate"-adj-0]|TX|2753/8|
00000000|MMI|3.46|Last|C1517741|[qlco]|["Last"-tx-7-"Last"-adj-0]|TX|1812/4|
00000000|MMI|3.46|Middle|C0444598|[spco]|["Mid"-tx-9-"mid"-adj-0]|TX|2749/3|
00000000|MMI|3.46|Moderate (severity modifier)|C0205081|[qlco]|["Moderate"-tx-9-"moderate"-adj-0]|TX|2753/8|
00000000|MMI|3.46|Moderate Extremity Pain|C4049705|[inpr]|["Moderate"-tx-9-"moderate"-adj-0]|TX|2753/8|
00000000|MMI|3.46|Moderation|C1881878|[qlco]|["MODERATE"-tx-9-"moderate"-adj-0]|TX|2753/8|
00000000|MMI|3.46|Saturated fat|C0597423|[food,orch]|["Saturated fat"-tx-3-"saturated fat"-noun-0]|TX|712/13|
00000000|MMI|3.46|Administration procedure|C1533734|[topp]|["Treatment"-tx-3-"Treatment"-noun-0]|TX|1159/9|
00000000|MMI|3.46|Biomaterial Treatment|C1705169|[cnce]|["Treatment"-tx-3-"Treatment"-noun-0]|TX|1159/9|
00000000|MMI|3.46|Primary|C0205225|[qlco]|["Principal"-tx-3-"PRINCIPAL"-adj-0]|TX|992/9|
00000000|MMI|3.46|Teaching principal|C0401925|[prog]|["Principal"-tx-3-"PRINCIPAL"-adj-0]|TX|992/9|
00000000|MMI|3.46|Therapeutic procedure|C0087111|[topp]|["Treatment"-tx-3-"Treatment"-noun-0]|TX|1159/9|E02
00000000|MMI|3.46|Treating|C1522326|[ftcn]|["Treatment"-tx-3-"Treatment"-noun-0]|TX|1159/9|
00000000|MMI|3.46|Treatment Epoch|C3538994|[resa]|["TREATMENT"-tx-3-"Treatment"-noun-0]|TX|1159/9|
00000000|MMI|3.46|treatment - ActInformationManagementReason|C3887704|[hlca]|["treatment"-tx-3-"Treatment"-noun-0]|TX|1159/9|
00000000|MMI|3.45|Coating (film)|C1522408|[qlco]|["Coated"-tx-3-"COATED"-adj-0]|TX|335/6|
00000000|MMI|3.45|Enteral|C1304890|[spco]|["Enteric"-tx-3-"ENTERIC"-adj-0]|TX|327/7|
00000000|MMI|3.45|sweaty|C0232427|[ftcn]|["Sweaty"-tx-5-"sweaty"-adj-0]|TX|1641/6|
00000000|MMI|3.45|Apical segmental vein|C0507238|[bpoc]|["V1"-tx-9-"v1"-noun-0]|TX|2654/2|
00000000|MMI|3.45|Biphasic|C0205184|[tmco]|["Biphasic"-tx-9-"biphasic"-adj-0]|TX|2643/8|
00000000|MMI|3.45|Elevation|C0702240|[spco]|["Elevation"-tx-9-"elevation"-noun-0]|TX|2670/9|
00000000|MMI|3.45|Elevation procedure|C0439775|[topp]|["Elevation"-tx-9-"elevation"-noun-0]|TX|2670/9|
00000000|MMI|3.45|Medical Device Emits Smoke|C1881674|[phpr]|["Smoking"-tx-14-"smoking"-noun-0]|TX|4022/7|
00000000|MMI|3.45|New|C0205314|[qlco]|["NEW"-tx-9-"new"-adj-0]|TX|2660/3|
00000000|MMI|3.45|Old|C0580836|[tmco]|["Old"-tx-9-"old"-noun-0]|TX|2683/3|
00000000|MMI|3.45|Posterior segmental vein|C0507237|[bpoc]|["V2"-tx-9-"v2"-noun-0]|TX|2680/2|
00000000|MMI|3.45|Room of building - Study|C0557651|[mnob]|["Study"-tx-3-"Study"-noun-0]|TX|1041/5|
00000000|MMI|3.45|Study|C2603343|[resa]|["Study"-tx-3-"Study"-noun-0]|TX|1041/5|
00000000|MMI|3.45|TRGV9 gene|C1421140|[gngm]|["V2"-tx-9-"v2"-noun-0]|TX|2680/2|
00000000|MMI|3.45|Tobacco smoking behavior|C0453996|[inbe]|["Smoking"-tx-14-"smoking"-noun-0]|TX|4022/7|
00000000|MMI|3.45|V1 stage|C0457422|[fndg]|["V1"-tx-9-"v1"-noun-0]|TX|2654/2|
00000000|MMI|3.45|V2 stage|C0457423|[fndg]|["V2"-tx-9-"v2"-noun-0]|TX|2680/2|
00000000|MMI|3.45|Vanadium 5+|C2349105|[elii]|["V5+"-tx-9-"v5"-noun-0]|TX|2657/2|
00000000|MMI|3.45|Acceptable|C1879533|[qlco]|["Acceptable"-tx-3-"acceptable"-adj-0]|TX|547/10|
00000000|MMI|3.45|Acceptable (foundation metadata concept)|C3539083|[qlco]|["Acceptable"-tx-3-"acceptable"-adj-0]|TX|547/10|
00000000|MMI|3.44|2000s|C0681760|[tmco]|["2000s"-tx-7-"2000"-integer-0]|TX|1821/4|
00000000|MMI|3.44|ANTICOAGULATION (finding)|C2919015|[fndg]|["ANTICOAGULATION"-tx-10-"anticoagulation"-noun-1]|TX|3078/15|
00000000|MMI|3.44|Anticoagulation Therapy|C0003281|[topp]|["anticoagulation"-tx-10-"anticoagulation"-noun-0]|TX|3078/15|
00000000|MMI|3.44|CXADR wt Allele|C3540475|[gngm]|["CAR"-tx-1-"CAR"-noun-0]|TX|103/3|
00000000|MMI|3.44|Coxsackievirus and Adenovirus Receptor|C3539542|[aapp]|["CAR"-tx-1-"CAR"-noun-0]|TX|103/3|
00000000|MMI|3.44|Decreased Coagulation Activity [PE]|C3537050|[phsf]|["Anticoagulation"-tx-10-"anticoagulation"-noun-1]|TX|3078/15|
00000000|MMI|3.44|Extreme|C0205403|[qlco]|["Extreme"-tx-14-"extreme"-adj-0]|TX|4139/7|
00000000|MMI|3.44|NR1I3 wt Allele|C3811749|[gngm]|["CAR"-tx-1-"CAR"-noun-0]|TX|103/3|
00000000|MMI|3.44|Negative Regulation of Coagulation|C2917212|[phsf]|["Anticoagulation"-tx-10-"anticoagulation"-noun-1]|TX|3078/15|
00000000|MMI|3.44|Now (temporal qualifier)|C1948052|[tmco]|["Now"-tx-13-"now"-adv-0]|TX|3908/3|
00000000|MMI|3.44|Pixels per Inch|C3811894|[idcn]|["PPI"-tx-3-"PPI"-noun-0]|TX|540/3|
00000000|MMI|3.44|Very severe|C3641272|[qlco]|["Extreme"-tx-14-"extreme"-adj-0]|TX|4139/7|
00000000|MMI|3.44|CALD1 gene|C1413086|[gngm]|["H-CAD"-tx-3-"h cad"-noun-0]|TX|1463/1,1467/3|
00000000|MMI|3.43|Beginning|C0439659|[tmco]|["Start"-tx-3-"Starting"-adj-0]|TX|479/8|
00000000|MMI|3.43|ABD tumor staging notation|C0449202|[inpr]|["ABD"-tx-9-"abd"-adj-0]|TX|2433/3|
00000000|MMI|3.43|Absence of Biallelic TCRgam